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Abstract: Triclosan (TCS) is a phenolic antimicrobial incorporated in personal 
care products and medical devices. Interest in the antiproliferative properties of TCS has 
recently grown owing to its antilipogenic effects. Through the studies presented here, we 
provide an appraisal of TCS as a chemotherapeutic agent by investigating its influence on 
the growth and survival of lymphoma cells. We also examine the contribution of TCS to 
the development of anemia; a major side effect of chemotherapy with a prevalence as 
high as 90% in cancer patients. Finally, we identify nonionic detergents, often used as 
excipients in drug formulations, as potent inhibitors of TCS in vivo. 
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Triclosan (TCS) is a synthetic, chlorinated phenolic antimicrobial agent commonly used in 
commercial and healthcare products. Items made with TCS include soaps, deodorants, 
shampoos, cosmetics, textiles, plastics, surgical sutures, and prosthetics. A wealth of 
information obtained from in vitro and in vivo studies have demonstrated the therapeutic 
effects of TCS, particularly against inflammatory skin conditions. Nevertheless, extensive 
investigations on the molecular aspects of TCS action have identified numerous adversaries 
associated with the disinfectant including oxidative injury and influence of physiological 
lifespan and longevity. This review presents a summary of the biochemical alterations 
pertaining to TCS exposure, with special emphasis on the diverse molecular pathways 
responsive to TCS that have been elucidated during the present decade. 
 
KEYWORDS: Triclosan; Gene regulation; Membrane & Cytoskeletal Damage; Cellular 




Triclosan (TCS), or 5-chloro-2-(2,4-dichlorophenoxy)phenol, is a synthetic broad- 
spectrum antimicrobial developed in the 1960s. As a polychlorinated bisphenolic 
compound, TCS has a perceptible aromatic odor, and is weakly soluble in water. It 
dissolves well in organic solvents including ethanol, dimethylsulfoxide (DMSO), and 
methanol (Montville and Schaffner, 2011), and the type of solvent and detergent 
availability seem to influence TCS activity (Kjaerheim et al., 1994a; Kjaerheim et al., 
1996; Skaare et al., 1997a). For example, TCS dissolved in oils (e.g., olive oil) and alkali 
(e.g., sodium carbonate) exhibits markedly reduced efficacy when compared to other 
solvents such as glycerol and polyethylene glycol (PEG) (Kjaerheim et al., 1994a; 
Kjaerheim et al., 1994b). In fact, using propylene glycol (PG) as a solvent renders TCS 
more effective than using PEG, which is probably due to micellar solubilization of TCS in 
the larger PEG molecules (Kjaerheim et al., 1994a). Recently, we have shown that the 
presence of non-ionic detergents (e.g., Tween 20) inhibits TCS activity in vivo, most likely 
due to micelle formation (Alfhili et al., 2018). In contrast, sodium dodecyl sulfate (SDS) 
has been reported to potentiate the antibacterial effect of TCS in vitro (Waaler et al., 1993). 
 
TCS has gained enormous popularity in commerce and in healthcare owing to its 
antibacterial, antiviral, and antifungal properties (Regos and Hitz, 1974; Regos et al., 1979; 
Bellamy et al., 1993). This efficacy has led to the widespread use of TCS as a preservative 
in a variety of consumer products, including cosmetics, soaps, mouthwashes, 
antiperspirants, kitchen utensils, clothing textiles, bedclothes, electronics, plastics, and toys 
(Triclosan White Paper prepared by The Alliance for the Prudent Use of Antibiotics 
(APUA)). In clinical practice, TCS is used as a disinfectant and an antiseptic in surgical 
4  
sutures, scrubs, implants, and medical devices (Rodricks et al., 2010; Petersen, 2016). 
Annual global production of TCS was estimated at 1500 tons (Chen et al., 2011), and a 
total of 132 million liters of TCS-containing products were consumed in a single year in 
the United States (Safety and Effectiveness of Consumer Antiseptics; Topical 
Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of 




The high demand for TCS has consequently led to substantial buildup in drinking and 
wastewater sources, and, more alarmingly, accumulation in body fluids (Schulze et al., 
1975; Adolfsson-Erici et al., 2002; Hovander et al., 2002; Geens et al., 2012; Wu et al., 
2012; Olaniyan et al., 2016; Weatherly and Gosse, 2017); establishing the antimicrobial as 
an environmental pollutant. Pharmacokinetic studies in man show that TCS reaches the 
systemic circulation by rapid absorption through the skin and mucous membranes of the 
oral cavity and gastrointestinal tract, and variations in the bioavailabilty of TCS 
unsurprisingly affect the rate of urinary excretion (Sandborgh-Englund et al., 2006; 
Queckenberg et al., 2010). TCS content in commercial products may reach as high as 17 
mM, and comprise up to 1% of ingredients (Levy, 2001; Rodricks et al., 2010; Weatherly 
and Gosse, 2017). Moreover, absorption of up to 25% of applied TCS has been recorded 
(Weatherly et al., 2018), and metabolic studies in rats and mice revealed sulfation, 
glucuronidation, and hydroxylation products in tissues and excreta (Moss et al., 2000; Fang 
et al., 2016). 
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Since the advent of TCS, early studies on the antiseptic have shown evidence of 
symptomatic relief from acne (Franz and Weidner-Strahl, 1978; Lee et al., 2003b) and 
contact dermatitis (Kalliomaki and Kuokkanen, 1979; Weitgasser et al., 1983) with fewer, 
or at least comparable, side effects to other therapeutic alternatives (Aliaga et al., 1983). 
Later, TCS was found to be effective against crural ulcer (Huber, 1991) and chemically 
induced dermatitis and desquamation (Barkvoll and Rolla, 1994; Skaare et al., 1996), 
which could be attributed to its anti-inflammatory (Kjaerheim et al., 1995a), 
hypoallergenic (Barkvoll and Rolla, 1995), and analgesic (Kjaerheim et al., 1995b) 
properties. Moreover, a battery of studies collectively indicate that TCS is not a skin or oral 
mucosal irritant, has a very low sensitization potential (0.1-0.3% of 14,000 subjects), and 
is unlikely to be phototoxic to human skin 
(http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf). This is in 
contrast to the reversible skin and eye irritation caused by up to 10% TCS reported in 
animals (http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf). 
Also, in initial studies by Lyman and Furia, it was suggested that TCS is carcinogenic when 
orally administered to rats (Lyman and Furia, 1968; Lyman and Furia, 1969). Subsequent 
investigations in rats and mice disclosed that TCS perturbs microsomal detoxification 
(Arrhenius et al., 1977), causes nephrotoxicity and hepatotoxicity (Chow et al., 1977), 
reduces prenatal and postnatal survival (Russell and Montgomery, 1980), and leads to 
central nervous system suppression (Miller et al., 1982) and hypothermia (Miller et al., 
1983). In humans, the earliest description of an adverse TCS reaction probably comes from 
a case report of two patients who developed contact dermatitis following application of 
deodorants containing 0.12% and 0.2% TCS (Roed-Petersen et al., 1975). Since then, 
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several case reports of the same ailment have thus far been in congruence (Veronesi et al., 
1986; Steinkjer and Braathen, 1988; Wong and Beck, 2001; Storer et al., 2004). It is 
important to mention that, as is the case with healthy subjects, in patients diagnosed with, 
or suspected to have, contact dermatitis, TCS was similarly found to have a very low 
sensitization potential (0.6-0.8% of 11,887 patients) 
(http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf). 
 
In light of the dichotomous debate surrounding TCS, the US Food and Drug 
Administration (FDA), following extensive examination of available data, has effectively 
banned antiseptic products containing TCS since September 2016 (Weatherly and Gosse, 
2017). In Europe, TCS was approved for use in cosmetics by the European Community 
Cosmetic  Directive    in     1986 
(http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf). However, 
the European Commission disapproved the use of TCS for hygienic purposes in 2017, but 
maintained its legality as a preservative in select cosmetics and mouthwashes in 
concentrations up  to 0.3% and  0.2%, respectively 
(http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_054.pdf; 
http://eur-lex.europa.eu/legal- 
content/EN/TXT/PDF/?uri=OJ:L:2014:107:FULL&from=EN).  Furthermore,  the 
Scientific Committee on Consumer Safety (SCCS) expressed its concern over the 
continued use of TCS in cosmetics, but not in antiseptics, mainly due to the cumulative 
pattern     of      exposure 
(http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_054.pdf). 
Importantly, the European Chemicals Agency (ECHA) classifies TCS, under the 
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classification, labeling, and packaging (CLP) regulation, as an eye irritant 2 (causes serious 
eye irritation), skin irritant 2 (causes skin irritation), aquatic acute 1 (very toxic to aquatic 
life), and aquatic chronic 1 (very toxic to aquatic life with long-lasting effects) 
(https://echa.europa.eu/documents/10162/21680461/bpc_opinion_triclosan_pt1_en.pdf/ef 
c985e4-8802-4ebb-8245-29708747a358). Because of the previously mentioned ecotoxic 
properties, TCS is currently a candidate for substitution under the Biocides European 





Our aim in this review is to provide an update on current knowledge regarding TCS 
therapeutic and toxic potential. Emphasis is placed on the biochemical and molecular 
alterations, either brought about by, or in response to, TCS exposure. Data from both in 
vitro and in vivo studies, obtained from humans and other organisms, are incorporated into 
the analysis, with special attention being given to reports published during the present 
decade. 
 
Membrane & Cytoskeletal Damage 
 
Perhaps the earliest report describing the antimicrobial activity of TCS was by Vischer 
et al., (Vischer and Regos, 1974) which was shown through topical application In a follow- 
up study, TCS was found to be more effective with the broadest spectrum against bacteria 
and fungi when compared to other antimicrobials such as gentamicin and clotrimazole 
(Regos et al., 1979). Subsequent efforts, which continue to this day, have focused on 
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dissecting the diverse action mechanisms and cellular targets of TCS. Initially, it was 
thought that TCS interacts with the prokaryotic cell membrane nonspecifically (Regos and 
Hitz, 1974). This was corroborated by the resistance of Gram-negative bacteria to TCS, 
which was ascribed to their outer membrane (Heath et al., 2000; Gilbert and McBain, 
2002). Investigating the genetic response of Mycobacterium tuberculosis to TCS, Betts et 
al. (Betts et al., 2003) identified perturbations in a wide assortment of genes involved in 
cell wall, transport, detoxification, and DNA replication and transcription. Also, Klebsiella 
pneumoniae with inactive efflux pump KpnGH exhibit pronounced susceptibility to 
multiple antibiotics including TCS (Srinivasan et al., 2014). Several genes in the membrane 
stress response pathway were also studied in Escherichia coli and Rhodospirillum rubrum 
S1H (Pycke et al., 2010; Gou et al., 2014; Lu et al., 2018). During the electro-Fenton 
transformation of TCS, significant changes in expression patterns of genes involved in cell 
wall and membrane structure, cell envelope, flagella, and multidrug efflux were observed 
(Table 1). These findings complement an earlier report describing enhanced resistance to 
TCS due to overexpressed acrAB multidrug efflux pump (McMurry et al., 1998a). It was 
recently suggested that TCS binds to the transcriptional repressor AcrR, causing 
conformational changes, and prevent its binding to the efflux pump AcrA promoter in 
Agrobacterium tumefaciens (Nuonming et al., 2018). 
 
The interaction of TCS with the cell membrane was also studied in human red blood 
cells (RBCs; erythrocytes). TCS exposure led to K+ leakage and overt hemolysis, 
indicating membrane damage, while antagonizing hypotonic lysis, which may be due to 
membrane expansion (Miller and Deinzer, 1980). TCS also inhibited membrane-bound 
Na+,K+,Mg2+-ATPase enzymatic activity (Lorusso et al., 1981). These observations 
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suggest that TCS causes membrane destabilization, perturbs monovalent ion transport, and 
modulates the overall osmoregulation of erythrocytes. Evidence for membrane damage is 
further confirmed in numerous studies by means of compromised stability and permeability 
(Villalain et al., 2001). To directly observe how TCS interacts with the cell membrane, 
Guillén and coworkers utilized nuclear magnetic resonance (NMR) spectroscopy to 
demonstrate that TCS intercalates within hydrophobic pockets in the lipid bilayer, 
perpendicularly to phospholipid molecules (Guillen et al., 2004). Furthermore, using 
neutral red to evaluate membrane integrity, diminished uptake of the dye in hemocytes of 
the clam Ruditapes philippinarum and mussel Mytilus galloprovincialis, was related to 
TCS-induced suppression of pinocytosis and disturbed phagocytosis (Canesi et al., 2007; 
Matozzo et al., 2012). 
 
Along those lines, our recent findings indicate that TCS blunts the expression of pmp3 
membrane transporter in Caenorhabitidis elegans nematodes, and that pmp3(ok1087) 
mutants exhibit increased sensitivity to the disinfectant (Yoon et al., 2017). Finally, a 
proteomic analysis of zebrafish (Danio rerio) larvae and gills of fresh water mussel 
Dreissena polymorpha, revealed alterations in cytoskeletal protein levels following TCS 
exposure (summarized in Table 1) (Riva et al., 2012; Falisse et al., 2017). 
 
There is a consensus in the literature regarding the membranotropic nature of TCS in 
different membrane models across various species. The cell membrane is a primary target 
for TCS, and among the first cellular obstacles that must be overcome by the antiseptic to 
exert its effects. Although evidence implicating membrane-associated efflux pumps as part 
of the cellular response to TCS is strong, there is paucity in reports describing TCS 
modulation of structural or functional membrane components in human-based systems. 
10  
Similarly lacking is an understanding of the role of membrane receptors not only in 
pumping out TCS molecules, but also in transducing both inter- and intracellular signals 












































































































































































































































































































Cytoskeleton; muscular filament structure 
 
 
Upregulated by TCS Downregulated by TCS Sensitive to TCS 
 






The interest in TCS and ultimate cell fate has originally stemmed from its use in oral 
hygiene products, which is reflected in two seminal studies on human gingival cells 
(Babich and Babich, 1997; Zuckerbraun et al., 1998). TCS was shown to be cytotoxic to 
gingival fibroblasts and epithelial cells, identifying it as a novel stimulator of apoptosis in 
the latter. 
 
Investigations have thus far followed a more comprehensive approach, relating cell 
death induced by TCS to other cellular adversaries, utilizing both human and non-human 
model systems. When TCS was treated to human choriocarcinoma placental cells (JEG-3), 
multiple dose- and time-dependent responses were observed (Honkisz et al., 2012). While 
there was a proportional increase in estradiol and progesterone secretion, β-human 
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chorionic gonadotropin (β-hCG) release was nevertheless inhibited with increasing TCS 
concentrations (Honkisz et al., 2012). In addition to blunted proliferation, significant cell 
death was recognized as apoptotic in nature evidenced by activated caspase-3 and Hoechst 
33342-stained fragmented DNA (Honkisz et al., 2012). Similarly, using anoikis-resistant 
H460 human lung cancer cells, Winitthana et al. (Winitthana et al., 2014) demonstrated 
that 24-hour exposure to 10 uM TCS causes cell death and apoptosis. Nontoxic levels (<7.5 
µM), however, enhanced cell growth (increased colony number and reduced size) without 
altering proliferation. TCS also promoted epithelial-to-mesenchymal transition (EMT), 
along with the migratory and invasive abilities of the cells (Winitthana et al., 2014). 
 
A research group performed a series of in vivo and in vitro studies on the effect of TCS 
on growth and proliferation of human BG-1 ovarian cancer cells. Results from these studies 
indicate that TCS increases cellular proliferation and both gene expression and protein 
levels of cyclin D1, and decreases p21 and Bax gene expression and protein levels (Kim et 
al., 2014). These effects were significantly antagonized by the estrogen receptor (ER) 
antagonist ICI 182,780, implicating ER in TCS-induced cell cycle progression and in its 
anti-apoptotic role. Investigators from the same group also reported a similar response to 
TCS by MCF-7 breast cancer cells and LNCaP prostate cancer cells. In MCF-7 cells, 1 uM 
TCS enhanced growth and proliferation during a six-day period, which was associated with 
increased cyclin D1 and reduced p21 expression levels. When mice were treated with TCS 
for 8 weeks, brdU-positive breast tumor cells were significantly increased compared to the 
control group treated with corn oil (Lee et al., 2014). Similar to BG-1 cells, TCS-promoted 
proliferation of MCF-7 cells was mediated through ERα signaling, demonstrated as 
antagonism by kaempferol and 3,3′-diindolylmethane (DIM); two phytoestrogens (Kim et 
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al., 2016). In addition to cyclin D1 and p21, TCS caused an increase in cyclin E and a 
decrease in Bax, and induced metastasis through elevated cathepsin D protein expression. 
These observations were paralleled in vivo using xenografted mouse models. Researchers 
from this report expanded their findings to VM7Luc4E2 cells, a variant of the MCF-7 
model, to show that TCS (0.1-10 µM) is pro-proliferative and anti-apoptotic by inhibiting 
oxidative stress, with both effects being antagonized by kaempferol (Lee et al., 2018). In 
LNCaP cells exposed to concentrations of TCS ranging from 0.01 to 10 uM for up to 5 
days showed enhanced proliferation and migration, and reduced p21 protein expression 
(Kim et al., 2015). In primary human syncytiotrophoblasts, TCS at 0.001 to 10 uM induced 
apoptosis as seen by condensed nuclei and fragmented DNA (Zhang et al., 2015). TCS also 
reduced 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) via a caspase-dependent 
mechanism. Other targets included both Bax and Bcl-2 proteins. 
 
Similar to human cells, both pro- and anti-apoptotic properties were observed in rodent 
cells treated with TCS. Beside its cytotoxicity, TCS caused caspase-dependent apoptosis 
in rat neural stem cells along with elevated Bax and reduced Bcl-2 (Park et al., 2016). In a 
series of studies, Szychowski et al. (Szychowski et al., 2015; Szychowski et al., 2016; 
Szychowski et al., 2018) used mouse neurons to show that TCS is apoptotic through the 
Fas receptor (FasR), aryl hydrocarbon receptor (AhR), and caspase activation involving N- 
Methyl-D-aspartate receptors (NMDARs). In agreement with the cytotoxicity data, TCS- 
treated mouse lung epithelial cells were deformed with reduced viability (Kwon et al., 
2013). Conversely, TCS stimulated the proliferation of mouse epidermis-derived JB6 Cl 
41-5a cells, by increasing cyclins D1 and A and inhibiting p27(Kip1) protein levels (Wu 
et al., 2015). Examining these effects in vivo, B6C3F1 mice exhibited epidermal 
16  
hyperplasia and focal necrosis following topical administration of TCS. Moreover, the 
pluripotency markers of mouse embryonic stem cells were analyzed following TCS 
exposure (Chen et al., 2015). Alkaline phosphatase (Alp), Sox2, Oct4, and Nanog were all 
reduced, while miRNA-134 was elevated. 
 
Unlike human and rodent cells, in vivo and in vitro studies on aquatic organisms 
uniformly agree that TCS is solely pro-apoptotic in these animals. Pyknotic apoptosis in 
the central nervous system of zebrafish D. rerio was observed following treatment with 
either TCS alone or TCS combined with derivatives 2,4,6-trichlorophenol (2,4,6-TCP) and 
2,4-dichlorophenol (2,4-DCP) (Kim et al., 2018; Liu et al., 2018). The TCS-derivative 
mixture caused pronounced deformities, behavioral abnormalities, and perturbed the 
expression of a panel of neurodevelopmental and apoptotic genes (Table 2). Also, TCS, 
following both in vivo and in vitro exposure, induced a dose- and time-dependent increase 
in apoptotic hemocytes of D. polymorpha (Binelli et al., 2009b; Binelli et al., 2009a). 
Likewise, when the saltwater clam Ruditapes philippinarum was treated with TCS, 
hemocytes exhibited significant cell death, blunted proliferation, reduced size and volume, 
and prominent apoptotic DNA fragmentation (Matozzo et al., 2012). TCS-induced 
apoptosis, or apoptosis-like cell death, was also detected in unicellular organisms, such as 
the green alga Chlamydomonas reinhardtii and the pathogenic fungus Cryptococcus 
neoformans (Movahed et al., 2016; Gonzalez-Pleiter et al., 2017). 
 
Collectively, studies on TCS influence on cell fate indicate estrogenic, proliferative, 
and apoptotic activities. Disturbances in genes and proteins governing the regulation of cell 
cycle and apoptosis are particularly sensitive to TCS modulation. The disparity in ultimate 
cell fate seem to point at an inter-species variation, and a dose-specific response, among 
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other experimental details such as cell type and duration of exposure. Elucidating the 
existence and the identity of a specific molecular ‘switch’ that may tip the scales in favor 
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Overwhelming evidence has recently accumulated in support of the pro-oxidative 
action of TCS. It is prudent to provide an overview of human-based studies first before 
summarizing notable findings obtained from other model organisms. 
 
In Porto Rican pregnant women, a correlation between exposure to TCS during 
pregnancy and oxidative damage, as measured by urinary 8-hydroxyguanosine (8-OHdG), 
and inflammation was suggested (Watkins et al., 2015). Similar observations were also 
mirrored in Chinese and Brazilian children (Lv et al., 2016; Rocha et al., 2018). 
Conversely, in a global effort comprising nine countries from Asia, Europe, and North 
America, no relation between urinary TCS and 8-OHdG was established (Iyer et al., 2018). 
 
In vitro studies on human cells have also shed some light on the oxidative potential of 
TCS. In peripheral blood mononuclear cells (PBMC), 2,4-dichlorophenol (2,4-DCP) –a 
product of TCS transformation– promoted reactive oxygen species (ROS) generation, with 
subsequent lipid peroxidation and protein carbonylation (Bukowska et al., 2016). 
Similarly, TCS caused elevated ROS in Nthy-ori 3-1 human follicular thyroid cells (Zhang 
et al., 2018) and lipid peroxidation in retinoblastoma (Y79 RB) cells (Vandhana et al., 
2013). Our recent investigations on mesenchymal stem cells also showed TCS interference 
 
Abbreviation: Shha, Sonic hedgehog a; Ngn1, Neurogenin1; Nrd, NeuroD; Elavl3, ELAV like; 
neuron-specific RNA binding protein 3; Gap43, Growth associated protein 43; Gfap, Glial 
fibrillary acidic protein; Mbp, Myelin basic protein 
 
Upregulated by TCS Downregulated by TCS Sensitive to TCS 
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with the activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the ‘master 
regulator’ of detoxification, and its downstream targets, heme oxygenase 1 (HO-1) and 
NAD(P)H dehydrogenase [quinone 1] (NQO-1) (Yoon et al., 2017). Consistently, TCS 
incorporated in mouthrinse did not exhibit antioxidant activity on fibroblasts (Battino et 
al., 2002). In contrast, TCS reduced ROS levels in VM7Luc4E2 cells, which contributed 
to its anti-apoptotic activity in these malignant breast cells (Lee et al., 2018). 
 
Mitochondrial damage was also evident in multiple mammalian cells including human 
PBMC and keratinocytes, exposed to 3.5-350 uM TCS (Ajao et al., 2015). At 
concentrations up to 100 uM, TCS caused depolarization of mitochondrial membrane, 
reduced oxidative phosphorylation, and suppressed ATP synthesis. Weatherly et al. 
(Weatherly et al., 2016). utilized human HMC-1.2 mast cells and primary keratinocytes 
to show that TCS is a proton ionophore uncoupler, and interferes with ATP production 
 
Animal studies conducted on mice and rats have revealed a profound response in the 
cellular antioxidant machinery upon TCS treatment. In rat thymocytes, superoxide anions 
were found to be elevated following TCS treatment (Tamura et al., 2012) which, as Yueh 
et al. (Yueh et al., 2014) showed, was met with increased expression of key antioxidant 
enzymes including HO-1, NQO-1, and glutathione S-transferase (GST) in mice liver. 
Evidence for testicular DNA damage, elevated malondialdehyde (MDA) and superoxide 
dismutase (SOD), in addition to diminished catalase (CAT), was related to TCS treatment 
in weanling rats (Riad et al., 2018). Similarly, in lung homogenates of female albino rats, 
TCS was found to induce lipid peroxidation, and severely deplete the levels of other crucial 
antioxidants; SOD, CAT, and glutathione (GSH) (Mohammed et al., 2017). Increased 
expression of glutathione peroxidase 1 (Gpx1) and aldehyde oxidase 1 (Aox1) was also 
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observed as a consequence to TCS exposure in C57BL/6 mice (Wang et al., 2017). Most 
recently, Zhang et al. (Zhang et al., 2018) showed downregulation of antioxidant enzymes, 
Gpx3, Cat, and Sod2, along with elevated MDA, in the hypothalamus of Sprague-Dawley 
rats. Moreover, it was found that TCS treatment leads to increased ROS and reduced GSH 
activity in rat neural stem cells (Park et al., 2016). TCS also increased ROS levels in mouse 
neocortical neurons, along with perturbed regulation of cytochrome P450 family 1, 
subfamily a, member 1 (CYP1a1) and CYP1b1 (Szychowski et al., 2016; Szychowski et 
al., 2018). Effects of TCS on cytochromes and hepatic detoxification were also 
demonstrated in Sprague-Dawley rats, showing increased levels of UDP- 
glucuronosyltransferase 1-1 (Ugt1a), Ugt2b1, CYP1a1, CYP1a2, CYP2b1, CYP3a1, and 
sulfotransferase family 1E member 1 (Sult1e1) (Zhang et al., 2018). 
 
Several terrestrial organisms have been employed in the study of TCS toxicology. 
Caenorhabtidis elegans is among the best-studied animal models due to its ease of 
maintenance and high genetic homology to humans. We have recently shown that TCS 
leads to overproduction of ROS, inhibition of nuclear translocation of protein skinhead-1 
(SKN-1) antioxidant transcription factor, and downregulation of gamma-glutamyl cysteine 
synthetase (Gcs1) (Yoon et al., 2017). In a subsequent report, Skn1 expression was found 
to be upregulated by TCS along with Sod1, Sod4, heat shock proteins (Hsp)-3, -4, -16.2, 
and -70, and cytochromes Cyp29A2 and Cyp34A9 
(https://app.dimensions.ai/details/publication/pub.1103154992#readcube-epdf). TCS also 
enhanced nuclear translocation of stress-related factor DAF-16, suggesting the occurrence 
of oxidative stress (Lenz et al., 2017). In the Earthworm Eisenia fetida, oxidative damage 
by TCS was manifested as a transient elevation in CAT and GST enzymes, increased 
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MDA, as well as DNA damage (Lin et al., 2010). In a follow-up study by the same group, 
SOD was also increased and decreased by TCS depending on the concentration used (Lin 
et al., 2012); a response mirrored by CAT in the snail Achatina fulica (Wang et al., 2014). 
In that study, TCS caused diminished levels of SOD and peroxidase (POD), along with 
elevated MDA, among other morphological anomalies. 
 
The ubiquity of TCS in aquatic environments has made animal models from that 
habitat the subject of extensive investigations on TCS toxicity. Perhaps the most relevant 
aquatic organism is the zebrafish D. rerio, owing to a strong structural and molecular 
resemblance to humans. Elucidating the interaction between TCS and the antioxidant 
system in ZFL liver cells, Zhou et al. (Zhou et al., 2017) showed evidence of induced 
CYP1A activity along with a general trend of suppression in phase I and II detoxification 
enzymes. Elevated MDA, along with perturbed homeostasis of GSH, peroxiredoxin-2 
(PRD-2) and HSPs were observed in zebrafish larvae grown in presence of TCS (Falisse 
et al., 2017; Liu et al., 2018). 
 
TCS has been shown to induce MDA and cause oscillations in CAT, Ethoxyresorufin- 
O-deethylase (EROD), erythromycin N-demethylase (ERND), and aminopyrine N- 
demethylase (APND) in Daphnia magna (Peng et al., 2013). Moreover, elevated amino 
acids, including glutamine, glutamate, and proline, has been attributed to a general 
oxidative stress state in the daphnids (Kovacevic et al., 2016). Also, stress-related proteins, 
including glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and hsp-70, were 
modulated by TCS in D. polymorpha, in addition to lipid peroxidation (Riva et al., 2012). 
TCS exposure demonstrated reduced oxyradicals and lipofuscin, and elevated oxidized 
glutathione (GSSG) in the digestive gland of swollen river mussels Unio tumidus 
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(Falfushynska et al., 2014). In Tigriopus japonicas copepods treated with TCS, increased 
ROS, SOD, GST, GPx, and GSH content was noted (Park et al., 2017). TCS also caused 
perturbations in expressional profiles of Cyps, Sod, Gst, and Cat proteins (Table 3) (Park 
et al., 2017). 
 
TCS treatment in the yellow catfish Pelteobagrus fulvidraco revealed induced CAT, 
EROD, ERND, and APND (Ku et al., 2014). Expressional profiling of Cyp1a, Cyp3a, and 
Gst showed both up- and downregulation depending on TCS concentration and length of 
exposure; a pattern that was also seen with MDA formation. When another catfish, 
Heteropneustes fossilis, was treated with a cosmetic effluent rich in TCS, increased SOD 
and CAT activities, and reduced GSH, GST, and GPx were noted (Banerjee et al., 2016). 
 
Oxidative damage by TCS was also evident in the goldfish Carassius auratus, as 
MDA, CAT, and GSH were elevated in addition to a reduced total antioxidant capacity 
(Wang et al., 2018b). Variable responses by antioxidant enzymes and in MDA levels were 
recorded in the goldfish’s liver after TCS treatment under a pH range of 6 to 9 (Li et al., 
2018). The oxidative potential of TCS was also evident in the rotifer Brachionus koreanus, 
detected as ROS overproduction and enhanced GST activity, in addition to transcriptional 
modulation of cytochromes, antioxidant genes Gst, Gpx, Sod, and Cat, and chaperons 
(Table 3) (Han et al., 2016). Moreover, TCS inhibited Sod and phospholipid hydroperoxide 
glutathione peroxidase (Phgpx) expression in the liver of Bufo gargarizans tadpoles (Chai 
et al., 2017), and induced GST in Pelophylax perezi frog larvae (Martins et al., 2017). 
 
Sendra et al. (Sendra et al., 2017) studied the combined effect of titanium dioxide 
(TiO2) and a heterogenous mixture of organic compounds including TCS using the clam 
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Ruditapes philippinarum. Modulations in EROD, SOD, CAT, GPx, GST, and GR enzyme 
activities were noted in the clam’s digestive gland, in parallel with increased lipid 
peroxidation.   TCS   exposure    caused    alterations    in    Cat,    Sod, Gpx1, Gpx2, 
Gsta, Hsp90bb, Hsp90ba, and Hsc70a genes in rainbow trout Oncorhynchus mykiss 
(Capkin et al., 2017). Although in one report TCS failed to elicit oxidative stress in the 
green algae Chlamydomonas reinhardtii (Almeida et al., 2017), another report detected 
ROS formation following TCS exposure (Gonzalez-Pleiter et al., 2017), which was also 
most recently confirmed by significantly increased MDA, downregulated Gpx, and 
upregulated Sod expression (Pan et al., 2018). 
 
The antimicrobial nature of TCS makes bacteria an appropriate target for mechanistic 
studies. Using Rhodospirillum rubrum S1H, Pycke et al. (Pycke et al., 2010) detected 
upregulation in a host of TCS-induced oxidative response genes, most notably Gpx. In E. 
coli K12, MG1655, the electro-Fenton transformation of TCS caused activation of genes 
related to ROS sensing, along with reduced glutaredoxin (Grx), Sod, Cat, and alkyl 
hydroperoxide reductase (Ahpr) (Gou et al., 2014). Very recently, ROS formation by TCS 
was associated with diminished expression of antioxidants in E. coli (Table 3); an event 
that preceded mutagenesis and enhanced drug resistance in that species (Lu et al., 2018). 
TCS was also recently used to validate novel self-luminescent bioreporter strains of Nostoc 
sp. PCC 7120 using Sod promoters (Hurtado-Gallego et al., 2018). 
 
Collectively, monumental evidence demonstrates the pro-oxidant properties of TCS 
evident as both overproduction of ROS as well as interference with the cellular antioxidant 
defensome. TCS is toxic in part by inducing oxidative damage in a wide range of organisms 
and by targeting a defined cluster of proteins in a fashion that is conserved among diverse 
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species. Nonetheless, the vast majority of data are collected from non-human models, and, 
as is the case with other toxicological reports of TCS, studies conducted on man or human- 
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Upregulated by TCS Downregulated by TCS Sensitive to TCS 
 
Abbreviation: TrxB, Thioredoxin; OsmC, Peroxiredoxin osmotically inducible protein C-like 
 
*Effects of 2,4-DCP; a byproduct of TCS degradation. 
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Immunity and Inflammation: 
 
TCS has, for a long time, been recognized as an effective therapy for infectious 
dermatitis (Kalliomaki and Kuokkanen, 1979; Aliaga et al., 1983; Weitgasser et al., 1983), 
and the observed curative capacity of the compound was solely attributed to its 
antimicrobial activity. It was not until the end of last century that associations between 
TCS exposure and remission of non-infectious inflammation were made (Barkvoll and 
Rolla, 1994; Barkvoll and Rolla, 1995; Kjaerheim et al., 1995a), and the use of 
antibacterials as anti-inflammatory agents has gained deserved attention during the past 
two decades. For example, an appreciable number of antibiotics, including macrolides and 
quinolones, have been shown to possess ant-inflammatory activity (Korzeniowski, 1989; 
Iino et al., 1992; Van Vlem et al., 1996; Culic et al., 2001; Uriarte et al., 2004). Follow-up 
efforts have successfully provided solid evidence for the direct interaction of TCS with 
inflammatory pathways. 
 
Gaffar et al. (Gaffar et al., 1995) reported that TCS inhibits cyclooxygenase-1 (COX- 
 
1) and COX-2, 5-lipoxygenase and (LPO), 15-LPO, interleukin (IL)-1β-induced 
prostaglandin E2 (PGE2) in gingival cells. TCS was also shown to suppress a wider range 
of inflammatory mediators including IL-1β-induced prostaglandin I2 (PGI2) and 
arachidonic acid, tumor necrosis factor (TNF)α-induced PGE2, phospholipase A2 (PLA2), 
and COX (Modeer et al., 1996). Moreover, in a double-blind crossover study, participants 
who used a mouthrinse with added 0.15% TCS developed significantly less oral 
erythematous lesions than those who used a TCS-free mouthrinse (Skaare et al., 1997b). 
By then, the anti-inflammatory properties of TCS were established and were widely 
accepted within the scientific and medical communities. 
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TCS in prosthetic devices was found to have no influence on the acute phase response 
(Hernandez-Richter et al., 2001), and only modest differences were seen between TCS and 
stannous fluoride dentrifice (Kumar, 2015). Nevertheless, TCS, when applied 
intracrevicularly, improved clinical parameters of ginigivits (Suresh et al., 2001). In a 
recent double-blind, randomized, crossover study, it was concluded that TCS-containing 
toothpaste inhibits inflammation in peri-implant tissue (Ribeiro et al., 2018). 
 
To date, elaborations on the anti-inflammatory nature of TCS have been the focus of 
subsequent studies. Mustafa et al. (Mustafa et al., 1998; Mustafa et al., 2000; Mustafa et 
al., 2005) identified IL-1β, interferon (IFN)γ, major histocompatibility complex (MHC) 
class II, and PGE synthase-1, as targets of TCS in human gingival fibroblasts. Of note, 
studies to discern the subcellular localization of TCS show preference for nuclear, as 
opposed to cytosolic, accumulation. Although initial uptake was considerably higher in the 
cytoplasm, a great proportion of cytosolic TCS was eliminated after repeated washing, 
while nuclear retention was observed (Mustafa et al., 2003). This may explain the 
perturbed inflammatory signaling associated with TCS. Moreover, in primary human oral 
epithelial cells, TCS attenuated LPS-induced cytokine response including IL-8, IL-1α, and 
TNFα, and aggravated the anti-microbial response, which was mediated through micro 
RNA (miRNA) regulation of toll-like receptor (TLR) pathway (Wallet et al., 2013). The 
findings were also reciprocated in cells derived from diabetic patients, with an exaggerated 
TLR response (Neiva et al., 2014). It was revealed that TCS, nevertheless, abrogated LPS- 
induced TLR response, again, through regulating miRNAs (stimulating miR146a and 
inhibiting miR155s). 
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In skin and leukocytes of mice topically treated with TCS, alterations in inflammatory 
responses were mediated through TLR4 (Marshall et al., 2017). Likewise, TCS 
downregulated parathyroid hormone (PTH)- or PGE2-stimulated matrix 
metalloproteinase-13 (MMP-13) expression in rat osteoblastic osteosarcoma cells (Barnes 
et al., 2013). Since hyperactive MMP-13 is implicated in periodontal disease, it was 
suggested that TCS might have a protective role against oral inflammatory conditions 
through its action on that enzyme, among others (Pancer et al., 2016). 
 
Interestingly, favorable results have been observed for TCS against other 
inflammatory conditions including cardiovascular disease and hidradenitis suppurativa 
(Cullinan et al., 2015; Hessam et al., 2016). Moreover, the use of TCS-impregnated 
ureteral stents seems to be a promising approach to combat urinary tract infections (UTI) 
and associated inflammation (Cadieux et al., 2006; Elwood et al., 2007). Along those lines, 
an increased urinary TCS was related to increased serum IL-6 in pregnant women (Watkins 
et al., 2015), pointing at a possible pro- or anti-inflammatory role. 
 
In a unique effort by Barros et al. (Barros et al., 2010), TCS modulation of the 
inflammatory response in an ex vivo whole blood stimulation assay was investigated. In 
that study, TCS inhibited multiple inflammatory mediators induced by LPS, including 
interleukins, most notably IL-1 & IL-6, IFNs, and colony-stimulating factor (CSF) 2. 
Activation of type 1 T helper lymphocytes was interrupted through the action of TCS on 
CD70. In a related report, TCS also reduced the capacity of natural killer (NK) 
lymphocytes to lyse chronic myelogenous leukemia K562 cells (Udoji et al., 2010). 
Recently, chitosan-TCS particles reduced the expression of IL-1β-induced Cox2 and Il6, 
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among other immune molecules in gingival fibroblasts (Table 4) (Pavez et al., 2018), 
showcasing the vast amenability of this antimicrobial to nanoparticle manipulation. 
 
Other in vivo studies on rodents and marine organisms clarified further the 
immunomodulatory properties of TCS. For instance, in mice subjected to an acute, 
systemic E. coli infection, Sharma et al. (Sharma et al., 2003) demonstrated that co- 
treatment with TCS significantly reversed the damage caused by the bacteria. Specifically, 
TCS prolonged survival, lessened hepatic congestion, hemorrhage, and fatty changes, and 
reduced blood liver enzymes, serum TNFα, and the severity of bacteremia. In accordance 
with published data, TCS was similarly immunosuppressive in aquatic mussels (M. 
galloprovincialis) and clams (R. philippinarum) (Canesi et al., 2007; Matozzo et al., 2012). 
 
Contrary to the overwhelming evidence of the anti-inflammatory function of TCS, a 
number of studies have nonetheless identified a pro-inflammatory role by the antiseptic. 
For example, upon intratracheal instillation of TCS in Sprague-Dawley rats, elevated total 
cell (TC) count, polymorphonuclear leukocytes (PMNs), total protein (TP), LDH, TNFα, 
and IL-6 were observed in bronchoalveolar lavage (BAL) fluid (Kwon et al., 2013), which, 
except for TP, returned to baseline levels after 14 days of exposure. Consonantly, it has 
also been demonstrated that TCS exacerbates diethylnitrosamine-induced hepatocellular 
carcinoma in C57BL/6 mice (Yueh et al., 2014). Likewise, TCS was very recently found 
to increase Tlr4 expression to promote colitis and aggravate colitis-related cancer in 
C57BL/6 mice (Yang et al., 2018). 
 
It is evident from the wealth of information present that TCS is a modulator of immune 
and inflammatory reactions. The sum of data from in vitro and in vivo studies indicate that 
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TCS, on its own, is immunosuppressive. Nevertheless, increasing evidence seems to 
suggest that in the presence of an existing adverse condition, such as inflammation or 
tumor, TCS further potentiates and worsens the eventual outcome. Investigations into the 
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Upregulated by TCS Downregulated by TCS Sensitive to TCS 
 
Abbreviation: MCP, Monocyte chemoattractant protein; TIMP, Tissue inhibitor of 
metalloproteinase; Bmp, Bone morphogenetic protein; Gdf, Growth differentiation factor; 




Genotoxicity and Carcinogenicity: 
 
Among the most important aspects of toxicological profiling of compounds is their 
interaction with the molecule of life – the DNA. Early efforts by Fahrig et al. (Russell and 
Montgomery, 1980; Kanetoshi et al., 1992) point at a possible role for TCS in somatic 
mutations observed in mice. TCS also caused a significant reduction in global DNA 
methylation in human hepatocellular carcinoma HepG2 cells; a finding associated with 
liver tumor (Ma et al., 2013). Similarly, TCS caused a dose-responsive increase in 
chromosomal aberrations in lung fibroblast V79 cells, but not in ovary CHO cells, of the 
Chinese hamster Cricetulus griseus (Rodricks et al., 2010). In a comparative study on 
Drosophila melanogaster using three mouthwashes, namely Cepacol® (0.05% 
cetylpyridinium chloride), Periograd® (0.12% chlorhexidinedigluconate), and Plax® 
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(0.03% TCS), it was concluded that only the ethanol content in Cepacol®, but not other 
active ingredients, caused mitotic recombination between homologues chromosomes 
(Rodrigues et al., 2007). On the other hand, TCS induced dose-responsive DNA damage 
in hemocytes of the zebra mussel D. polymorpha (Binelli et al., 2009a), and strand breaks 
in the digestive gland of U. tumidus mussels (Falfushynska et al., 2014). A similar dose- 
dependent DNA damage was also observed in the Earthworm E. fetida (Lin et al., 2010; 
Lin et al., 2012), but not in E. andrei (Chevillot et al., 2018). 
 
Comparing TCS to other toxicants in the larvae of freshwater insect Chironomus 
riparius, Martínez-Paz et al. (Martinez-Paz et al., 2013) found TCS, along with 
nonylphenol, to be the most potent in causing DNA breakage. It was also noted that TCS, 
either alone or in combination with carbendazim, induced DNA damage in D. magna (Silva 
et al., 2015). Using the brine shrimp Artemia salina, a time-dependent pattern of TCS- 
induced genotoxicity was identified (Xu et al., 2015). Moreover, TCS was genotoxic in the 
catfish Heteropneustes fossilis, goldfish C. auratus, and rainbow trout O. mykiss (Banerjee 
et al., 2016; Capkin et al., 2017; Wang et al., 2018b). Importantly, when TCS at an 
environmentally relevant concentration (3 nM) was treated to the freshwater protozoan 
Tetrahymena thermophila, notable DNA damage, without significant perturbation in 
growth or cell viability, was evident (Gao et al., 2015). In a more detailed study on E. coli, 
Gou et al. (Gou et al., 2014) revealed that the electro-Fenton transformation of TCS caused 
upregulation of a host of genes involved in the DNA repair machinery, indicative of DNA 
stress. These genes belong to base excision repair (mutT and nfo), nucleotide exision repair 
(uvrA and uvrD), mismatch repair (uvrD and ssb) and double-strand break repair (ssb and 
recN). Chromosomal stickiness, reduced mitotic activity, and ana-telophase bridges were 
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also noticeable in the bulb onion Allium cepa following TCS treatment (Herrero et al., 
2012). 
 
In a recent proof-of-concept study, the promising potential of a toxicogenomic 
approach as a follow-up to positive in vitro genotoxicity data was evaluated. Using TCS as 
a testing compound, it was shown that the antimicrobial is non-DNA reactive, and that it 
is genotoxic solely in vitro as opposed to in vivo (Doktorova et al., 2014). 
 
Ambiguity surrounding the carcinogenicity of TCS still remains today. Investigators 
have generally been able to provide evidence for carcinogenic effects in animal models but 
not in humans. Of the earliest studies in this regard was a report by Lyman et al. (Lyman 
and Furia, 1969) identifying TCS as a carcinogen in mice. Other studies on mice have been 
in agreement with that conclusion. For example, it was noted that chronic TCS exposure 
increased the incidence of liver neoplasms (Rodricks et al., 2010), and aggravated 
hepatocellular carcinoma (Yueh et al., 2014). Furthermore, TCS caused colonic 
inflammation and worsened colitis or tumorigenesis induced by dextran sodium sulfate 
(Sanidad et al., 2018). These findings, were, however, not paralleled in rats, hamsters, or 
baboons (Bhargava and Leonard, 1996; Rodricks et al., 2010). More importantly, in vivo 
human studies of TCS are scarce, and aspects related to TCS-induced oncogenesis are 
lacking. Consequently, whether TCS poses a carcinogenic hazard to humans is unknown 
and requires further investigation. Nonetheless, the interaction of TCS with human-derived 
cancer cells in vitro has recently gained considerable attention (reviewed under Therapeutic 
Proposals). 
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In light of available data, TCS demonstrates carcinogenicity solely in mice, and within 
a narrow range of tissues (the liver and colon), which constitutes limited evidence of 
carcinogenicity  according   to    ECHA 
(https://echa.europa.eu/documents/10162/23036412/clp_en.pdf/58b5dc6d-ac2a-4910- 
9702-e9e1f5051cc5). Hence,  TCS is not classifiable as a carcinogen 
(http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_054.pdf). 
It must be noted that in case future assessment conclusively rules out TCS as a human 
carcinogen, caution with its use must still be exercised given the established 
carcinogenicity of its transformation products – dioxins, chloroform, and anilines (Halden 
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Adaptations to the ever-changing intracellular and surrounding environments are 
achieved, in large part, by effective communication. Transmission of information that carry 
specific instructions is executed by messengers that function in tandem within a defined 
pathway. Tasks, however, are usually accomplished through the sequential transduction of 
multiple messages along a complex, intertwining network that involves a wide assortment 
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of mediators (Uings and Farrow, 2000). Hence, the participation of cell signaling cascades 
in the response to xenobiotics cannot be overlooked. 
 
The use of human cell lines has provided a wealth of information particularly 
regarding the study of signaling molecules responsive to stressors and xenobiotics, 
including TCS. In H460 lung cancer cells, TCS promoted migration and invasion through 
focal adhesion kinase/ATP dependent tyrosine kinase (FAK/Akt) and Ras-related C3 
botulinum toxin substrate 1 (Rac1) (Winitthana et al., 2014). Evidence similarly exists for 
the classical mitogen-activated protein kinases (MAPK) as targets of TCS. For example, 
proliferation of JB6 Cl 41-5a cells as induced by TCS was accompanied by activation of 
extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinases (JNK), and 
p38 MAPKs, in addition to Akt (Wu et al., 2015). Importantly, blocking either MEK1/2 or 
phosphoinositide 3-kinase (PI3K) significantly attenuated TCS-induced proliferation. In 
another study on rat neural stem cells, TCS-induced cytotoxicity and apoptosis were 
accompanied by activation of p38 and JNK, and suppression of ERK, Akt, and PI3K (Park 
et al., 2016). This points at the involvement of these proteins in both cellular survival and 
death as brought about by TCS. Recently, TCS was shown to activate p38 and JNK in vivo 
as detected in the hypothalamus of Sprague-Dawley rats and in vitro utilizing human Nthy- 
ori 3-1 thyroid follicular cells (Zhang et al., 2018). In that study, TCS stimulated 
thyrotropin-releasing hormone receptor through p38 MAPK, which, in turn, influenced 
thyroid peroxidase (TPO) level. 
 
In suppressing TLR signaling in whole blood leukocytes, TCS downregulated the 
expression of several signaling mediators, most notably, NF-kB-inducing kinase (Nik) and 
C-jun, which accounted for the overall blunted inflammatory response to LPS in these cells 
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(Barros et al., 2010). Furthermore, suppression of Mmp-13 expression in mouse 
osteoblastic osteocarcinoma cells by TCS was possibly related to its inhibition of Fos/Jun 
and AP-1 sequence binding in both the Mmp-13 and C-fos promoters (Barnes et al., 2013). 
 
The endocrine-disrupting activity of TCS, specifically its estrogenicity, has been of 
great interest to researchers. Kim et al. (Kim et al., 2014) utilized BG-1 ovarian cancer 
cells to show that the proliferative effects of TCS were mediated through ERα. Confirming 
the ER role, the use of ICI 182,780 reversed the proliferative properties of TCS along with 
associated perturbations in cyclin D1, p21, and Bax expression and protein levels. 
Likewise, the ER is implicated in TCS-induced proliferation of MCF-7 cells and increased 
breast tumor mass in mice (Lee et al., 2014; Kim et al., 2016; Lee et al., 2017b). This was 
similarly indicated by TCS inhibition with ICI 182,780 or kaempferol, and the stimulation 
of insulin-like growth factor (IGF) signaling, namely phosphorylated insulin receptor 
substrate (pIRS-1), pAkt, pMEK1/2 and pERK1/2 (Kim et al., 2016). Notably, kaempferol 
also inhibited TCS-induced VM7Luc4E2 cell growth (Lee et al., 2018). These observations 
are in congruence with an earlier report by Huang et al. (Huang et al., 2014) describing the 
estrogenic activities of nanomolar concentrations of TCS in the same cells. Investigating 
ER-responsive genes on the transcriptional and translational levels, it was shown that TCS 
induced pS2 but blunted ERα mRNA and protein levels the latter of which was related to 
elevated miR-22, miR-206, and miR-193b miRNAs. 
 
Recent studies have also argued for the dual effect of TCS on ER signaling. For 
example, Henry et al. (Henry and Fair, 2013) demonstrated that, when administered alone 
to MCF7 cells, TCS at 7 nM to 700 µM exhibits estrogenic activity but becomes anti- 
estrogenic in presence of E2. Along those lines, it was shown that TCS, on its own, lacked 
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any effect on rat uterine growth, but could still potentiate the effect of ethinylestradiol (EE) 
(Stoker et al., 2010). In a follow-up investigation, it was reported that TCS promotes EE- 
induced inhibition of ERα and ERβ expression, and when given alone does not activate ER 
at concentrations from 30 nM to 100 µM (Louis et al., 2013). Furthermore, TCS diminished 
E2 and estrogen sulfotransferase in sheep placenta (James et al., 2010). This is in contrast 
to the increased activity of ERβ but not ERα caused by a TCS-derivative mixture, which 
led to neurological and behavioral abnormalities in zebrafish (Liu et al., 2018). Also, 
Sprague-Dawley rats given TCS showed increased uterine weight and Calbindin-d(9k) 
(CaBP-9k) expression, which was also reciprocated in pituitary GH3 cells (Jung et al., 
2012). Reversal of both anomalies by ICI 182,780 and RU 486 points at a possible 
estrogenic role of the antimicrobial. 
 
Very recently, Serra et al. (Serra et al., 2018) challenged accumulating evidence of 
TCS estrogenicity by showing the lack of agonistic or antagonistic effect in vivo and in 
vitro. While up to 0.3 µM TCS did not modulate ER-dependent brain aromatase in 
zebrafish embryos, interference with the enzyme’s activity, and with E2 activation of the 
enzyme observed at 1 µM, was not attributed to TCS-ER interaction. Moreover, up to 10 
µM TCS lacked estrogenic effects in ER-expressing zebrafish liver cells as well as in MCF- 
7 cells (Serra et al., 2018). Additionally, in a screening study of the estrogenicity of a group 
of endocrine-disrupting chemicals on fish species, TCS failed to significantly elicit a 
response in an in vitro ERα reporter gene assay (Miyagawa et al., 2014). 
 
In light of available evidence, the general consensus seems to indicate that the 
estrogenicity of TCS is contingent upon multiple factors, including concentration, species, 
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duration of exposure, and whether TCS is administered alone or in combination with other 
molecules. 
 
With regard to the androgenic properties of TCS, it was revealed that TCS interferes 
with testosterone (TSN)-related transcription but promotes that dependent on androgen 
(Chen et al., 2007; Christen et al., 2010). In a recent in vivo study on weanling male rats, 
Riad et al. (Riad et al., 2018) reported that TCS, either alone or combined with 
butylparaben, reduced TSN, leutinizing hormone (LH), and follicle-stimulating hormone 
(FSH), while increased E2 was observed upon single TCS administration Also, TCS- 
induced proliferation and migration of LNCaP cells were significantly reduced in presence 
of bicalutamide, an androgen receptor (AR) antagonist (Kim et al., 2015). These findings 
support a previous report by Ahn et al. (Ahn et al., 2008) in which 1 µM TCS reduced E2- 
induced ER activation by 50% and AR in human BG1Luc4E2 ovarian adenocarcinoma 
cells and T47D-ARE breast cancer cells, respectively. Evidence for TCS estrogenicity was 
detected in MCF7 cells when [(3)H]estradiol was successfully displaced from the ER by 
the antimicrobial (Gee et al., 2008). Furthermore, 10 µM TCS attenuated E2-dependent 
ERE-CAT reporter gene induction, while 0.1 and 1 µM TCS inhibited TSN-stimulated 
LTR-CAT reporter gene in both T47D cells and S115 mouse mammary tumor cells (Gee 
et al., 2008). TCS was also determined to have a weak effect on AhR in recombinant rat 
hepatoma (H4L1.1c4) cells. Finally, Forgacs et al. (Forgacs et al., 2012) showed that TCS 
interferes with recombinant hCG stimulation of TSN in a novel BLTK1 murine Leydig cell 
model. Most recently, however, no significant influence on androgen synthesis or activity 
by TCS was observed in Wistar rats (Farmer et al., 2018). 
55  
Controversy surrounding the interaction between TCS and members of the peroxisome 
proliferator-activated receptors (PPARs) has gained considerable attention as of late. This 
has essentially stemmed from the apparent discrepancy between data obtained from 
humans and those from rodents. In comparing the differential modulation of TCS on 
PPARα in HepG2 cells and mouse hepatoma Hepa1c1c7 cells, distinct responses were 
observed by Wu et al. (Wu et al., 2014). Protein levels of PPARα downstream target, acyl- 
coenzyme A oxidase, were decreased in HepG2 cells but were increased in Hepa1c1c7, 
which also showed higher DNA synthesis and blunted apoptosis through transforming 
growth factor (TGF-β). PPAR signaling was similarly identified as a target of TCS through 
genome-wide CRISPR-Cas9 screening in HepG2 cells (Xia et al., 2016), zebrafish 
(Haggard et al., 2016), and Gallus gallus chicken embryos (Guo et al., 2018). In the latter 
model, PPAR signaling members Cyp7a1, fatty acid binding protein 1 (Fabp1), acyl-CoA 
synthetase long-chain family member 5 (Acsl5), acyl-CoA oxidase 2 (Acox2), perilipin 1 
(Plin1) were upregulated, whereas angiopoietin like 4 (Angptl) was downregulated. 
 
TCS administered to pregnant mice caused insulin resistance, hypothyroidism, 
diminished glucose transporter 4 (GLUT4) expression, and inhibition of Akt and mTOR 
phosphorylation (Cao et al., 2017; Hua et al., 2017). While thyroxine corrected these 
adversaries, PPARγ activator, rosiglitazone, solely reversed the decrease in Akt 
phosphorylation in adipose tissue and in muscle (Hua et al., 2017). PPARγ is known to 
ameliorate mTOR suppression-induced glucose intolerance in rats (Festuccia et al., 2014), 
further underlining the far-reaching effects of TCS action. 
 
Although TCS has been reported to promote hepatocyte proliferation in mice through 
PPAR (Rodricks et al., 2010), Yueh et al. (Yueh et al., 2014) found no appreciable 
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induction of PPARα following TCS treatment. Importantly, the authors also identified 
constitutive androstane receptor (CAR) as a possible aggravator of TCS-induced 
tumorigenesis, given the halved tumor number in Car–/− mice compared to their Car+/− 
counterparts. TCS, as is the case with PPARs, is reported to exhibit varying affinities for 
CAR and pregnane X receptor (PXR) in humans and rodents. A weak agonist for human 
CAR, TCS was found to be a reverse agonist for rodent CAR, an agonist for human PXR, 
and had no effect on rodent PXR (Paul et al., 2013). 
 
Calcium concentration within cells influences protein conformation and dynamics. 
Protein binding of Ca2+, on the other hand, maintains the ion’s content within a 
physiological range and sets forth diverse cellular activities related to gene expression, 
motility, secretion, and survival (Clapham, 2007). Beside proteins, intracellular Ca2+ levels 
are modulated by a variety of stimuli, including xenobiotic exposure. Through the Ca2+ 
channel ryanodine (Ry) receptor type 1 (RyR1), TCS increased cytosolic Ca2+ dose- 
dependently in primary skeletal myotubes irrespective of extracellular Ca2+ (Ahn et al., 
2008). Accordingly, muscle contractility was compromised upon TCS exposure in vitro 
and in vivo (Cherednichenko et al., 2012). Results from this study indicate that TCS 
impaired excitation-contraction coupling (ECC) in cardiac and skeletal muscles, and 
enhanced electrically-induced Ca2+ transients in myotubes without depleting intracellular 
Ca2+ and notwithstanding RyR1 blockage. TCS also efficiently blocked excitation-coupled 
Ca2+ entry and interfered with the bidirectional signaling between RyR1 channels and Ca2+ 
ions. Likewise, TCS compromised ECC in larval fathead minnows Pimephales promelas, 
as evidenced by altered RyR and dihydropyridine receptor (DHPR) mRNA and protein 
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levels, and weakened ligand binding to both receptors in adult muscle homogenates 
(Fritsch et al., 2013). 
In rat thymocytes, TCS elevated intracellular Ca2+ levels, and opened Ca2+-responsive 
K+ channels, eventually leading to membrane hyperpolarization (Kawanai, 2011). Also, 
TCS prevented Ca2+-induced mitochondrial swelling in rat liver (Teplova et al., 2017). A 
more in-depth analysis of TCS modulation of Ca2+ homeostasis was conducted on rat 
basophilic leukemia (RBL) mast cells (Weatherly et al., 2018). In this cell type, TCS 
caused mitochondrial fission, diminished membrane potential and translocation, with 
compromised ATP production and elevated ROS. These changes were associated with 
perturbed mitochondrial and endoplasmic reticulum Ca2+ and depleted cytosolic Ca2+ 
levels following antigen stimulation. Accordingly, TCS-induced degranulation of mast cell 
may at least in part be attributed to Ca2+ mobilization. 
Calcium modulation by TCS has also been investigated in other organisms. In C. 
reinhardtii exposed to 14 µM TCS, increased Ca2+ levels with oxidative stress, cell and 
mitochondrial membrane depolarization, compromised photosynthesis, and caspase 
activation were noted (Gonzalez-Pleiter et al., 2017). Importantly, chelation of intracellular 
Ca2+ ions by BAPTA-AM protected the algae from TCS-induced Ca2+ dysregulation. 
These observations strongly implicate Ca2+ as a mediator of a wide array of toxic anomalies 
attributed to TCS. 
 
Literature concerning the xenobiotic response to TCS has revealed important signaling 
pathways activated or suppressed by TCS (Table 6). Distinct outcomes exist among 
species, and even within the same species based on experimental conditions and model 
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under investigation. Although important milestones in TCS signaling have been achieved 
so far, there remains a lot to be discovered, especially in human-based systems, about the 
modulatory effects of TCS on cellular physiology. In particular, the response of many 
human cell types and tissues to TCS treatment is unknown, and identification of signaling 
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The first specific action mechanism of TCS in prokaryotes was only demonstrated 20 
years ago, when inhibition of fatty acid synthesis in Escherichia coli was noted following 
exposure to TCS (McMurry et al., 1998b; McDonnell and Russell, 1999). TCS irreversibly 
inhibited the fatty acid biosynthesis enzyme, enoyl–acyl carrier protein reductase (ACP), 
by mimicking its natural substrate in vivo. Further, a mutated or an overexpressed ACP, 
encoded by fabI, was shown to confer TCS resistance in the bacterium. These findings 
established ACP as a specific, subcellular TCS target. Efforts have thus far revealed the 
susceptibility of a host of other pathogens to fatty acid synthesis by TCS. These include 
Staphylococcus aureus, M. tuberculosis, Helicobacter pylori, Haemophilus influenzae, 
Plasmodium falciparum, Toxoplasma gondii, Leishmania spp., and Trypanosoma spp. 
((Heath et al., 2000; Parikh et al., 2000; Beeson et al., 2001; Marcinkeviciene et al., 2001; 
McLeod et al., 2001; Surolia and Surolia, 2001; Lee et al., 2002; Roberts et al., 2003). In 
humans, fatty acid synthase (FAS) is the only multi-enzyme complex that is responsible 
for the endogenous synthesis of saturated fatty acids from acetyl-CoA and malonyl-CoA 
(Lu and Archer, 2005; Lupu and Menendez, 2006). Although a BLAST analysis of E. coli 
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FabI protein and FAS showed no homology, appreciable sequence similarities were 
nevertheless found with polyketide synthase and type I FAS of M. tuberculosis (Liu et al., 
2002). 
 
The success of cerulenin, a mycotoxin with fatty acid inhibitory action, in suppressing 
tumor progression in vivo has spawned several reports in support of fatty acid synthesis 
inhibition as an emerging target for chemotherapy (Pizer et al., 1996). The earliest study 
in this regard investigated the cytotoxicity of TCS in MCF-7 and SKBr-3 breast cancer 
cells (Liu et al., 2002). It was revealed that TCS at 10-50 uM is cytotoxic, anti-proliferative, 
induces morphological alterations, and inhibits FAS. These findings corroborate an earlier 
observation linking FAS inhibition with apoptotic death of breast cancer cells (Kuhajda et 
al., 1994; Kuhajda et al., 2000; Liu et al., 2002). TCS was similarly found to inhibit the 
development of methylnitrosourea-induced breast cancer in Sprague-Dawley rats (Lu and 
Archer, 2005). In human A-375 melanoma cells, TCS inhibited growth at 40 uM (Ho et 
al., 2007). TCS was similarly found to be dose-dependently pro-apoptotic in prostate 
cancer cells, with IC50 values as low as 4.5-7.8 uM (Sadowski et al., 2014). Whereas no 
cytotoxicity was observed in NIH3T3 fibroblasts at concentrations up to 60 uM, values of 
IC50 ranging from 0.74-62 uM were nonetheless observed in non-malignant prostate cells. 
This suggests two things; first, that prostate cells are relatively more sensitive to TCS 
toxicity than fibroblasts and presumably other non-malignant cell types, and second, that 
malignant prostate cells exhibit higher chemosensitivity compared to their non-malignant 
counterparts. This differential susceptibility could be due to overexpressed FAS in 
malignant cells. However, in contrast to these reports, at concentrations up to 345 uM, TCS 
was found to be preferentially cytotoxic to Y79 RB cells over mouse 3T3 fibroblasts and 
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human MIO-M1 Müller glia cells as indicated by IC50 values, creating a large therapeutic 
index of 7.1 and 5.3 respectively (Deepa et al., 2012). FAS suppression, depleted fatty acid 
content, lipid peroxidation, and apoptotic death were noted in Y79 RB cells at the same 
TCS concentration range (Vandhana et al., 2013). Recently, TCS at 40 uM was also shown 
to be effective against MiaPaCa-2 and AsPC-1 pancreatic cancer cells suppressing 
proliferation, and eliciting apoptotic death (Nishi et al., 2016). Of note, in a related study, 
TCS impeded mouse pre-adipocyte differentiation (Schmid et al., 2005). Given the 
regulation of food intake by FAS, and the susceptibility of adipocyte development to TCS 
inhibition, it was suggested that TCS may possess anti-obesogenic properties. 
 
The differential expression and activity of FAS in healthy and malignant tissues, where 
it is up-regulated in the latter (Pizer et al., 1997; Wilentz et al., 2000), indicates a possibly 
high therapeutic index. The long history of human use, and the ubiquity of TCS in 
consumer products, coupled with encouraging in vivo results, cements the antimicrobial as 
a promising candidate for chemotherapy. As noted earlier, it must be stressed that 
variations in the final outcome of TCS treatment largely depend on experimental setup. 
Moreover, limited data from animal studies suggest that in presence of a preexisting tumor, 
TCS administration seems to exacerbate the condition. This observation is concerning, and 
indeed warrants further investigation before TCS can be invested in for clinical trials. 
 
Conclusion and specific aims: 
 
TCS is a synthetic antimicrobial with a long history of human use. At concentrations 
well below those present in commercial products, data from in vitro and in vivo studies 
have provided evidence of adverse effects on diverse molecular pathways. Most alarmingly 
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is TCS enhancement of malignant cell proliferation in vitro and tumor growth in vivo. On 
the other hand, TCS has also been shown to be protective against malignant cell growth 
and proliferation, possibly opening the door for its use in chemotherapy. Clearly, dose and 
time dependence is an important factor in determining the eventual denouement of the 
chemical. In spite of the numerous publications dissecting the signaling pathways 
responsive to TCS, it is evident that a severe paucity surrounding human-based in vivo and 
in vitro studies still remains today. Future studies, thus, should focus on identifying 
signaling molecules differentially regulated by TCS, and characterize their roles in toxic 
or protective effects in different cell types. Insights gained from such revelations will be 
invaluable to possibly validate targets for drug development, or devise possible TCS 
adjuvants or inhibitors. 
 
The objective of this work is to provide an appraisal of the utility of TCS in 
chemotherapy. Toward this aim, we will investigate the influence of TCS on the growth 
and proliferation of leukemia cells, and delineate the molecular mechanisms underlying 
such an effect. Also, given the high prevalence of chemotherapy-induced anemia in cancer 
patients, we will study the interaction of TCS with human erythrocytes to elucidate the 
potential hemolytic properties of the antimicrobial. Finally, we plan to model drug 
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Burkitt's lymphoma (BL) is the fastest growing human tumor. Current treatment consists 
of a multiagent regimen of cytotoxic drugs with serious side effects including tumor lysis, 
cardiotoxicity, hepatic impairment, neuropathy, myelosuppression, increased 
susceptibility to malignancy, and death. Furthermore, accessibility of therapeutic 
interventions in areas of BL prevalence are not as feasible as in high-income countries. 
Therefore, there exists an urgent need to identify new therapies with safer profile and 
accessibility. Triclosan (TCS), an antimicrobial used in personal care products and surgical 
scrubs, has gained considerable interest as an antitumor agent due to its interference with 
fatty acid synthesis. Here, we investigate the antitumor properties and associated molecular 
mechanisms of TCS in Burkitt lymphoma BJAB cells. A dose-dependent cell death was 
observed following treatment with 10-100 µM TCS for 24 h, which was associated with 
membrane phospholipid scrambling, compromised permeability, and cell shrinkage. TCS- 
induced cell death was accompanied by a elevated intracellular calcium, perturbed redox 
balance, chromatin condensation, and DNA fragmentation. TCS upregulated Bad 
expression and downregulated that of Bcl2. Moreover, caspase and JNK MAPK signaling 
were required for the full apoptotic activity of TCS. In conclusion, this report identifies 
TCS as an antileukemic agent and provides new insights into the molecular mechanisms 
governing TCS-induced apoptosis in BL cells. 
 




Burkitt lymphoma (BL) is a malignant tumor of B lymphocytes, with metastatic 
dissemination to the nervous system, bone marrow, and abdominal tissue (Dozzo et al., 
2017). The most aggressive human tumor (Molyneux et al., 2012), BL is often caused by 
a chromosomal translocation of immunoglobulin and c-MYC genes. Malignant 
transformation is strongly associated with Epstein-Barr virus (EBV), human 
immunodeficiency virus (HIV), and malaria (Molyneux et al., 2012), although BL still 
occurs in absence of infection. Affecting patients of all age groups, BL is the most common 
cancer in children where malaria is holoendemic (Orem et al., 2007). 
 
The currently approved treatment for BL consists of a multiagent regimen 
colloquially known as CHOP (cyclophosphamide, doxorubicin, vincristine, and 
prednisolone). This standard approach remains insufficient, and short-intensive, periodical 
treatment plans are most often required, consisting of methotrexate, cytarabine, etoposide, 
ifosfamide, and carboplatin (Dozzo et al., 2017). However, constrained by economic 
factors, therapeutic interventions in areas where BL is more prevalent, as in Africa, are not 
as feasible as in high-income countries (Molyneux et al., 2012). Prognosis is similarly 
negatively influenced by such a reality (Hesseling et al., 2005). Furthermore, serious side 
effects of existing BL treatment include tumor lysis, cardiotoxicity, hepatic impairment, 
neuropathy, hemorrhagic cystitis, myelosuppression, and increased susceptibility to 
malignancy (Molyneux et al., 2012; Casulo and Friedberg, 2015; Ahlmann and Hempel, 
2016; Kurauchi et al., 2017; Luu et al., 2018). More alarming has been the mortality 
attributed to therapy in about 5% of BL patients (Hesseling et al., 2005; Hesseling et al., 
2009). Of note, antiretroviral therapy has thus far failed to reduce the incidence of 
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immunodeficiency-associated BL (Casulo and Friedberg, 2015). Therefore, there exists an 
urgent need to identify alternative therapies with preferentially lesser side effects and 
improved accessibility (Hesseling et al., 2009; Schmitz et al., 2012). 
 
Triclosan (TCS; 2,4,4´-trichloro-2´-hydroxydiphenyl ether; CAS 3380-34-5) is a 
broad-spectrum antimicrobial used in a wide variety of commercial products including 
household items, cosmetics, soaps, toothpastes, lotions, deodorants, and surgical scrubs 
(Jones et al., 2000). The mechanism of TCS action, aside from the disruption of cell 
membrane integrity (Guillen et al., 2004), relies on its inhibition of fatty acid synthase 
(McMurry et al., 1998b). This has ignited an interest among researchers to further explore 
the potential use of TCS as a chemotherapeutic agent by targeting fatty acid synthesis; a 
major source of energy in malignant cells (Schcolnik-Cabrera et al., 2018). 
 
To date, conflict in the literature regarding the effect of TCS on ultimate cell fate 
still exists. While several reports have described the antiproliferative activity of TCS in 
MCF-7 breast cancer cells (Liu et al., 2002; Vandhana et al., 2010), recent findings indicate 
that TCS promotes MCF-7 growth and invasion (Lee et al., 2014; Lee et al., 2017a; Lee et 
al., 2017b). A similar response was also observed in LNCaP prostate cancer cells 
(Sadowski et al., 2014; Kim et al., 2015) and H460 lung cancer cells (Winitthana et al., 
2014). Thus, the contrasting reports on the denouement of TCS exposure and the duality 
of its role poses a viable and feasibly exploitable avenue to further explicate its 
antineoplastic potential. Herein, we investigate the interaction of TCS with BJAB Burkitt 
lymphoma cells, and delineate the molecular mechanisms governing the antitumor role of 
the antimicrobial. 
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MATERIALS AND METHODS: 
 
Chemicals and reagents: 
 
All chemicals are of analytical grade and were purchased from MilliporeSigma 
(Burlington, MA, USA) unless otherwise noted. A stock solution of TCS was prepared in 
ethanol at 10 mM, and further diluted to testing concentrations in RPMI-1640 medium. 
Intracellular Ca2+ chelator glycine, N,N'-[1,2-ethanediylbis(oxy-2,1-phenylene)]bis[N-[2- 
[(acetyloxy)methoxy]-2-oxoethyl]]-, bis[(acetyloxy)methyl] ester (BTM) was purchased 
from Thermo Fisher Scientific (Waltham, MA, USA), p38 MAPK inhibitor SB2035080 
(SB) was from Selleckchem (Houston, TX, USA), while c-Jun N-terminal kinase (JNK) 
inhibitor XVI (JNK-IN-8) and pan-caspase inhibitor zVAD(OH)-fmk (zVAD) were from 
Cayman Chemical Company (Ann Arbor, MI, USA). All inhibitors were dissolved in 
dimethyl sulfoxide (DMSO) and then diluted to desired concentrations in RPMI-1640 prior 




B cell acute lymphoblastic leukemia BJAB cell line was grown at 370C with 5% 
CO2 in RPMI-1640 medium supplemented with 0.3 g/L L-glutamnie, 10% heat-inactivated 




Dual acridine orange/ethidium bromide (AO/EB) staining was utilized to 
distinguish live and dead cells based on membrane integrity. Control and treated cells were 
mixed with an equal volume of AO/EB staining solution (AO = 1 µg/ml; EB = 20 µg/ml), 
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loaded on a hemocytometer, and live and dead cells were counted and imaged with EVOS® 
fl Digital Inverted Microscope (Thermo). 
 
Phosphatidylserine (PS) externalization, membrane integrity, and cellular 
dimensions: 
 
Identification of the mode of cell death was achieved using Annexin-V-FITC (AV) 
and propidium iodide (PI) supravital staining (Thermo). Following treatment, cells were 
washed twice in PBS, resuspended in Annexin binding buffer, and double-stained with 
1.25% v/v Annexin-V-FITC and 20 µg/ml PI for 20 min at room temperature away from 
light. Two-dimensional analysis was subsequently carried out on a FACScan flow 
cytometer (Betcon Dickinson, Franklin Lakes, NJ, USA) at excitation and emission 
wavelengths of 488/530 (FITC) and 535/617 nm (PI), respectively. Forward scatter (FSC) 




Generation of reactive oxygen species (ROS) was detected by the cell-permeant 
probe 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA; Thermo). This 
nonfluorescent probe is oxidized by intracellular ROS into DCF whose fluorescence is 
proportional to ROS levels. Cells were preloaded with 2 µM H2DCFDA for 45 min at 37
0C. 
treated with TCS for 30 min, washed in PBS to remove excess, unbound dye, and 
fluorescence was analyzed on a FACScan at an excitation wavelength of 495 nm and an 




Cell-permeable Ca2+ indicator Fluo3/AM (Biotium, Fremont, CA, USA) was 
utilized to measure cytosolic Ca2+ content. Nonfluorescent Fluo3/AM is hydrolyzed by 
intracellular esterases into Fluo3 whose fluorescence increases upon Ca2+ binding. To 
measure cytoplasmic Ca2+ levels, control and treated cells were washed in PBS, suspended 
in 2.5 mM CaCl2 solution containing 1 µM Fluo3/AM for 30 min at 37
0C in the dark, 
washed again in PBS, and finally subjected to FACS analysis. Fluo3 was excited by the 
488 argon-ion laser and emitted fluorescence was detected at 530 nm. Control and 
experimental cells were imaged with EVOS® fl Digital Inverted Microscope following 
staining with 5 µM Fluo3/AM. 
 
Nuclear chromatin condensation: 
 
Control and treated cells were incubated with 100 ng/ml Hoechst 33342 for 30 min 
at room temperature in the dark, and then imaged with EVOS® fl Digital Inverted 
Microscope. 
 
Oligonucleosomal DNA fragmentation: 
 
Genomic DNA was isolated from control and treated cells using Qiagen’s DNeasy 
Blood & Tissue Kit (Qiagen, Germantown, MD, USA) according to the manufacturer’s 
instructions. A total of 200 ng of extracted DNA was fractioned by 0.7% agarose gel 
electrophoresis, visualized with EB, and documented with UVP MultiDoc-ItTM UV trans- 
illuminator. 
 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR): 
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Total RNA was extracted using Qiagen’s RNeasy Mini Kit and assessed for 
quality and quantity on NanoDrop 1000 Spectrophotometer V3.7 (Thermo). A total of 1 
µg of RNA was denatured and reverse transcribed to cDNA using SuperScript™ III First- 
Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). Synthesized cDNA was 
amplified by qRT-PCR (Bio-Rad iQTM5 Multicolor RT-PCR Detection System) using 
PowerUp™ SYBR™ Green Master Mix (Applied Bioscience, Carlsbad, CA, USA) and 
Sigma’s KiCqStart® SYBR® Green primers for CAT, SOD, GPX, GSR, BAD, BCL2, 
H2AFX, PARP1, and ACTB. Relative quantification of gene expression was achieved 




Results are expressed as means + S.E.M. Comparative analysis among the means 
 
was performed by Student’s t-test or one-way ANOVA with Dunnett’s post hoc test as 
analyzed by Prism 5.0 (GraphPad Software, San Diego, CA, USA). Significance was 




TCS induces cell death dose-dependently 
 
The cell membrane is a primary target of TCS (Villalain et al., 2001; Lygre et al., 
2003; Guillen et al., 2004). To assess the cytotoxic potential of TCS, BJAB cells were 
treated with 10-100 µM TCS for 24 h at 370C, and live and dead cells were distinguished 
based on membrane integrity as determined by AO/EB double staining. While AO stains 
live and dead cells green, EB only penetrates through damaged membranes imparting a red 
fluorescence on dead cells. As shown in Figure 1B&C, an exponential increase in the 
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percentage of EB-stained cells is observed with increasing TCS concentrations, an effect 
attaining statistical significance at 30 µM. This indicates a dose-dependent cytotoxic effect 
by TCS against B-cell lymphoma cells. 
 
TCS stimulates both AV and PI uptake 
 
To identify the pattern of cell death inflicted by TCS, a FACS analysis with AV 
and PI labeling was employed. Whereas AV is taken up by PS-exposing cells, those with 
a ruptured membrane are permeable to PI. Figure 2 shows that while untreated cells exclude 
both dyes, significantly increased AV and PI uptake was observed for TCS-treated cells. 
At 50 µM, TCS caused a significant increase in the percentage of AV-/PI+ cells from 2% + 
0.499 to 49.36% + 14.16. For cells treated with 75 µM TCS, AV+/PI+ cells represented a 
 
significant increase to 16.55% + 4.98, compared to a control value of 5.37% + 0.91, while 
those showing AV-/PI+ were 76.49% + 2.58; a significant increase from 2% + 0.499 in the 
case of control cells. Taken together, these data, coupled with the virtual absence of cells 
solely bound to AV, seem to implicate late apoptosis that has progressed to secondary 
necrosis as a mode of death. 
 
TCS-induced cell death is accompanied by shrinkage and enhanced granularity 
 
One of the morphological hallmarks of dying cells is shrinkage and increased 
granularity (Lizard et al., 1995; Lizard, 2001), seen as a decrease in FSC due to cell 
condensation and an increase in SSC due to surface complexity. Light scatter properties 
were therefore analyzed in order to estimate cell size and granularity following TCS 
treatment. 
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As depicted in Figure 3A-D, TCS exposure caused a significant decrease in FSC 
geomean from an average of 525.1 + 22.52 (control) to 422.9 + 25.68 (50 µM) and  304.9 
+ 27.35 (75 µM). The percentage of cells with a reduced FSC (<400) also increased from 
 
3.92% + 0.55 (control) to 15.65% + 3.78 (50 µM) and 32.72% + 3.07 (75 µM), while that 
 
of cells with FSC >800 significantly diminished following treatment with 75 µM TCS 
(11.43 + 1.99 vs. 1.98 + 0.79). As for SSC, significant elevations were noted following 
treatment with TCS (Figure 3E-G). At 75 µM TCS increased SSC geomean from 133 + 
 
9.30 to 175.72 + 17.60. Also, the percentage of cells with enhanced SSC increased from 
 
8.29 + 0.28 to 19.73 + 2.12 (50 µM) and 18.79 + 1.79 (75 µM). 
 
 
Collectively, the significant changes in cellular dimensions indicate that TCS 
treatment alters the light scatter behavior of cells, reflective of cellular shrinkage and 
increased surface complexity; two distinctive features of apoptotic cells. 
 
 
TCS increases intracellular Ca2+ accumulation 
 
Calcium is a major regulator of apoptosis. To assess the role of Ca2+ in TCS- 
induced cell death, cells were incubated with and without 25-75 µM TCS at 370C for 30 
min and stained with Fluo3 as described earlier. Figure 4A-C show that Fluo3 fluorescence 
intensity rises to 16.63 + 1.38 (50 µM) and 25.27 + 4.02 (75 µM) relative to an average of 
5.0 + 0.65 in the case of control cells. A significant increase in the percentage of cells with 
 
enhanced Fluo3 fluorescence was also detected at 50 µM (34.31% + 4.47) and 75 µM 
 
(42.85% + 3.31) TCS compared to control cells (8.89% + 1.25). 
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Because TCS lead to elevated Ca2+ levels, we were prompted to determine the 
contribution of Ca2+ mobilization to TCS-induced cell death. To this end, cells were 
incubated for 24 h at 370C in presence or absence of 50 µM TCS with and without 1 h 
pretreatment with 10 µM BTM, and cytotoxicity was then examined by AV/PI staining. 
As depicted in Figure 4 E&F, no significant difference in cell death was observed in 
presence of BTM compared to its absence (59.45 + 3.56 vs. 56.67 + 5.76), which indicates 
that TCS-induced Ca2+ increase was not necessary for the full apoptotic activity of TCS. 
 
TCS causes oxidative stress 
 
Perturbations in cellular redox state and excessive ROS production are associated 
with apoptosis. In order to examine the effect of TCS on ROS levels, cells were preloaded 
with 2 µM H2DCFDA for 45 min at 37
0C and then either left untreated or exposed to 25- 
75 µM TCS for an additional 30 min, before DCF fluorescence was subsequently detected 
as described earlier. Data in Figure 5A-C indicate that, compared to a control value of 2.89 
+  0.17,  TCS  at  50  and  75  µM  significantly  increased  the  average  geomean  DCF 
 
fluorescence to 5.90 + 0.49 and 8.0 + 0.62, respectively. The percentage of cells with 
 
enhanced  fluorescence  also  significantly increased  from  an  average  of  2.95%  + 0.24 
 
(control) to 14.01% + 2.24 (50 µM TCS) and 22.23% + 1.80 (75 µM TCS). 
 
 
Given the observed oxidative stress, it was of interest to identify the effect of TCS 
on redox enzymes regulating ROS levels. For this purpose, gene expression of key 
antioxidant enzymes was examined by qRT-PCR. As shown in Figure 5D-G, TCS 
significantly downregulated CAT, SOD, GPX, and GSR expression at all concentrations 
tested. Furthermore, we evaluated the contribution of oxidative stress in TCS-induced cell 
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death by incubating the cells for 24 h with and without 50 µM TCS in presence or absence 
of 1 mM ROS scavenger N-acetylcysteine (NAC). As seen in Figure 5 H&I, the percentage 
of cell death in presence of NAC is not significantly different from its absence (54.41% + 
3.47 vs. 55.45% + 2.97). This indicates that TCS treatment induces oxidative stress which 
 
is nevertheless apparently not required for its full cytotoxic effect. 
 
TCS perturbs BAD and BCL2 gene expression 
 
The expression pattern of Bcl-2 genes regulates apoptosis and participates in tumor 
progression. To interrogate the influence of TCS on BAD and BCL2 gene expression, 
control and treated cells were subjected to qRT-PCR analysis as described earlier. Figure 
6A shows that TCS significantly upregulates the proapoptotic BAD gene expression and 
significantly downregulates that of the antiapoptotic BCL2. This pattern is consistent with 
apoptosis and complements other findings in this study. 
 
TCS triggers DNA damage 
 
A prominent feature of apoptotic cells is systematically fragmented DNA. To 
elucidate the effect of TCS on DNA integrity, cells were treated with 25-75 µM for 24 h, 
and multiple methods were subsequently employed. Initially, nuclear condensation was 
evaluated by Hoechst 33342; a widely used DNA-binding dye whose fluorescence intensity 
is proportional to chromatin condensation. Figure 7A shows enhanced fluorescence in 
presence of TCS compared to the control cells, reflective of pyknotic nuclei. 
 
Next, we examined the degree of DNA fragmentation as caused by TCS exposure. 
The electrophoretic pattern in Figure 7B depicts oligomers of DNA extracted from control 
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and TCS-treated cells. While no significant DNA degradation is observed in untreated 
cells, those exposed to TCS exhibit pronounced fragmentation. Finally, in an attempt to 
investigate impaired or responsive DNA repair pathways, we analyzed mRNA expression 
profiles of major repair genes including γH2AFX and PARP1. TCS upregulated H2AX 
expression (Figure 7C) and downregulated that of PARP1 (Figure 7D). Taken together, 
these data provide evidence of compromised DNA integrity and repair mechanisms 
characteristic of cellular death. 
 
TCS-induced cell death is mediated through caspase and JNK signaling 
 
Multiple signaling pathways are implicated in the regulation of cell survival and 
response to stress stimuli. To identify signaling mediators required for the full cytotoxic 
activity of TCS, cells were preincubated with 100 µM zVAD(OH)-fmk, 100 µM Nec-1, 50 
nM NSA, 5 µM SB203580, or 5 µM U0126 for 1 h, or with 5 µM JNK-IN-8 for 3 h, before 
they were treated with 50 µM TCS for 24 h. 
 
As shown in Figure 8A, TCS-induced cell death was significantly, but not 
thoroughly, ameliorated in presence of zVAD (58.08 + 2.49 vs. 41.64 + 3.02), indicating 
that TCS is cytotoxic in caspase-dependent and independent mechanisms. Similarly, Figure 
8D shows that JNK inhibition significantly protects the cells against TCS toxicity (44.29 + 
4.12 vs. 35.25 + 2.21) identifying JNK as a requirement for the full cytotoxic effect of TCS. 
 
Notably, blockade of key elements of necroptosis signaling failed to significantly reverse 
TCS-induced cell death. These observations, along with other findings in this study, are 





TCS is a widely used antimicrobial with a long history of use in commercial 
products and clinical practice. Although previous reports have discerned both pro- and 
antitumor activities, the effect of TCS on blood malignancies has largely been overlooked. 
To the best of our knowledge, this report is the first to identify TCS as an anti- 
leukemic/anti-lymphoma agent. It was revealed that TCS induced apoptosis in Burkitt 
lymphoma cells at least in part through dysregulated calcium homeostasis, oxidative stress, 
and nuclear fragmentation. Moreover, the antitumor effect of TCS was mediated through 
caspase and JNK signaling. TCS concentrations used in this study are several orders of 
magnitude lower than those present in consumer products (Rodricks et al., 2010) and are 
within the range shown to be cytotoxic to a variety of cells (Liu et al., 2002; Ho et al., 
2007; Sadowski et al., 2014). 
 
During apoptosis, cells display a reduced volume (Figure 3A-D) as the cytosolic 
accumulation of Ca2+ (Figure 4A-D) activates Ca2+-responsive K+ channels leading to loss 
of KCl and osmotically obliged water (Lang et al., 2006b). A reduced FSC may also 
indicate dying cells as they fragment into smaller apoptotic bodies (Bortner and Cidlowski, 
2007). Although it is unknown what advantage this morphological hallmark gives to dying 
cells, it is thought to facilitate their engulfment by larger phagocytes. A coarser and more 
granular cell surface (Figure 3E-G) may result from wrinkled membrane or internal 
complexity reflecting changes in number and shape of intracellular organelles (Ramirez et 
al., 2013). 
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One important distinction that must be borne in mind is one between necrotic cell 
rupture and the disruption of cell membrane by TCS. As a lipophilic compound, TCS 
readily diffuses into the membrane where it is positioned perpendicularly to the 
phospholipid bilayer (Guillen et al., 2004). Consequently, alterations in membrane 
permeability ensue. Along those lines, our results show that TCS-treated cells become 
permeable to EB and PI (Figures 1 & 2), indicating compromised membrane integrity. 
Therefore, caution must be exercised in interpreting EB/PI-positive cells as necrotic 
especially in light of solid evidence of apoptotic transformation. In fact, apoptotic cells are 
recognized by phagocytes via the display of the “eat me” signal (i.e. PS externalization). 
However, given the absence of phagocytes in vitro, the membrane of apoptotic cells 
eventually loses its permeability becoming permissive to vital dyes (secondary necrosis) 
(Silva, 2010). 
 
Calcium plays a crucial role in innumerable cellular processes, including signal 
transduction and regulated cell death. The asymmetrical architecture of phospholipids in 
the cell membrane is controlled by Ca2+-dependent scramblases, and Ca2+ accumulation 
(Figure 4) stimulates PS exposure (Figure 2) possibly through dysregulated activity of 
enzymes and transmembrane proteins (Suzuki et al., 2010). It has also been observed that 
inordinate liberation of sequestered Ca2+ ions from the endoplasmic reticulum into the 
mitochondria contributes to apoptosis by dephosphorylating Bad and opening of 
mitochondrial permeability transition pore (Zhivotovsky and Orrenius, 2011). Sustained 
pore opening causes a spill out of mitochondrial content, most notably Ca2+ ions and 
apoptosome components, and water influx, eventually leading to mitochondrial swelling 
and rupture. Furthermore, cytosolic Ca2+ accumulation leads to systematic DNA 
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fragmentation (Figure 7B) by activating Ca2+- and Mg2+-dependent endonuclease (Wyllie, 
1980). Similarly, the intranuclear presence of Ca2+ has been shown to influence chromatin 
organization (Figure 6A), modulate gene expression, and activate caspases (Zhivotovsky 
and Orrenius, 2011). 
 
We have also shown that TCS-induced apoptosis of B lymphoid cells is partially 
mediated through oxidative stress (Figure 5). Excessive generation of ROS contributes to 
nucleic acid (Figure 7), protein, lipid, and organelle damage, which in turn initiates the 
cellular death machinery (Redza-Dutordoir and Averill-Bates, 2016). This is in congruence 
with our previous report of TCS interference with the antioxidant master regulator, Nrf2, 
in primary human mesenchymal stem cells (Yoon et al., 2017). Recent studies have also 
described the prooxidative effect of TCS in thyroid follicular epithelial Nthy-ori 3-1 cells 
(Zhang et al., 2018) and retinoblastoma Y79 cells (Vandhana et al., 2013). Interestingly, 
TCS rather diminished ROS levels in MCF-7 variant breast carcinoma VM7Luc4E2 cells 
(Lee et al., 2018) as part of its antiapoptotic activity. 
 
Moreover, ROS activate p53 or JNK which unbalances mitochondrial Bcl2 proteins in 
favor of apoptosis. ROS similarly depolarize the mitochondrial membrane which facilitates 
the liberation of cytochrome c from to the cytoplasm where it forms the apoptosome in 
association with Apaf-1 and procaspase-9. Consequently, effector caspases (e.g.,  caspase 
3) execute apoptosis by cleaving cellular proteins (Redza-Dutordoir and Averill-Bates, 
2016). Indeed, we found that TCS upregulates BAD expression and downregulates that of 
BCL2 (Figure 6). BAD contributes to tumorigenesis (Marchion et al., 2011) and 
overexpression sensitizes tumor cells to apoptotic stimuli (Mok et al., 1999; Taghiyev et 
al., 2003) and reduces tumorigenicity (Jiang et al., 2013). BCL2 overexpression has  been 
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observed in follicular lymphomas (Fernandez et al., 2019) and is known to favor prostate 
cancer progression and metastasis (Furuya et al., 1996; Zellweger et al., 2005), and 
resistance to apoptosis in pancreatic tumor (Bold et al., 2001). 
 
A late feature of apoptotic cell death is systematic DNA cleavage by endonucleases 
downstream of caspase-3 (Collins et al., 1997). Apoptosis through the extrinsic or intrinsic 
pathways converge at activated caspase-3 which initiates DNA fragmentation. 
Nevertheless, apoptosis-inducing factor (AIF) and endonuclease G are both liberated from 
the mitochondria and may degrade the DNA independent of caspase activation (Elmore, 
2007). ROS may also directly oxidize the DNA (Redza-Dutordoir and Averill-Bates, 
2016). Since caspase (Figure 8A), but not ROS (Figure 5H&I), inhibition significantly 
rescued the cells from TCS-induced apoptosis, it follows then that DNA fragmentation 
(Figure 7B) in B-cell lymphoblasts, as caused by TCS, is most likely mediated through 
caspase stimulation. 
 
Our results also show that TCS upregulates H2AX expression (Figure 6C). H2AX 
encodes for H2A Histone Family Member X whose phosphorylation (γ-H2AX) is induced 
by double-strand breaks and a stalled replication fork (Gagou et al., 2010). In fact, 
phosphorylation at Ser-139 is induced by DNA fragmentation during apoptosis (Rogakou 
et al., 2000). Also, knockdown of both copies of H2AX in mice caused lymphoma and solid 
tumors (Bassing et al., 2003), suggesting that H2AX could be possess a tumor suppressing 
role (Kuo and Yang, 2008) which may therefore be targeted for therapy (Shay and 
Roninson, 2004). Some treatment modalities activate DNA repair to induce senescence in 
cancer cells (Shay and Roninson, 2004). It is important to note that radiation therapy is 
100  
known to induce DNA breaks, and γ-H2AX formation serves as a biomarker for 
radiosensitivity of cancer cells (Taneja et al., 2004). 
 
PARP1 encodes for poly(ADP-ribose) polymerase 1, an enzyme involved in chromatin 
remodeling, DNA repair, differentiation, proliferation, and tumorigenesis (Ahel et al., 
2008). As shown in Figure 6D, TCS downregulated PARP1 expression which indicates 
impeded proliferation and impaired DNA repair. Interference with DNA damage response 
has recently gained considerable interest for the development of novel chemotherapeutics, 
some of which are currently used in the clinic for various cancers (Ray Chaudhuri and 
Nussenzweig, 2017). Likewise, targeting PARP1 shows promise for cardiovascular and 
nervous disease (Pillai et al., 2006; Reinemund et al., 2009)). 
 
Our small-molecule inhibitor studies demonstrate that TCS-induced cell death is 
significantly, but not thoroughly, ameliorated under conditions of caspase inhibition 
(Figure 8A). Thus, TCS induces apoptosis in B cell lymphoma cells through caspase- 
dependent and independent mechanisms. Similarly, caspase activation by TCS has been 
detected in human primary placental syncytiotrophoblasts (Zhang et al., 2015) and 
choriocarcinoma JEG-3 cells (Honkisz et al., 2012). 
 
MAPKs are involved in the regulation of many cellular functions including 
proliferation, differentiation, apoptosis, and response to various stimuli. Activation of p38 
induces apoptosis (Wada and Penninger, 2004), and cells not rescued by ERK inhibition 
(Figure 7C) is congruent with its described role as a survival factor (Harada et al., 2004). 
On the other hand, Figure 8D shows that JNK inhibition attenuates TCS-induced cell death, 
identifying JNK as a target for TCS and as a requirement for its full apoptotic activity in 
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lymphoblastic leukemia B cells. JNK promotes proliferation and paradoxically many types 
of programmed cell death, including apoptosis (Wada and Penninger, 2004), depending on 
cell type and stimulus (Dhanasekaran and Reddy, 2008; Dhanasekaran and Reddy, 2017). 
In fact, maintenance of JNK in a dephosphorylated state has been shown to prevent 
apoptosis and hence contribute to therapy resistance (Candas et al., 2014). Accordingly, 
JNK activation accompanied TCS-induced apoptosis in rat neural stem cells (Park et al., 
2016) and hypothyroidism in Sprague-Dawley rats (Zhang et al., 2018). Conversely, TCS- 
induced proliferation of mouse epidermal JB6 Cl 41-5a cells was associated with, but did 
not require, JNK activity (Wu et al., 2015). 
 
Because impaired apoptosis is a hallmark of carcinogenesis, targeting apoptotic defects 
is an effective intervention that forms the basis behind the action mechanism of numerous 
chemotherapeutic agents (Wong, 2011). Drugs that modulate the Bcl-2 family of proteins 
and those that activate caspases are currently being investigated in clinical trials for 
different tumors including leukemias and lymphomas (Wong, 2011; Jiang et al., 2013). 
Other apoptotic hallmarks, such as Ca2+ overload and oxidative stress, have similarly been 
investigated as therapeutic targets (Giorgi et al., 2010; Ndombera et al., 2016). 
Furthermore, monoclonal antibody (mAb)-based therapies, administered either in isolation 
or conjugated to chemotherapeutic drugs, have also demonstrated efficacy against various 
diseases with more than 30 antibodies currently approved for treatment (Liu, 2014). Of 
particular relevance to BL is rituximab, an anti-CD20 mAb, which significantly improved 
BL prognosis in young and adult populations alike (Dozzo et al., 2017). Finally, 
microRNAs have recently been identified as regulators of cell death, survival, and 
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chemosensitivity in B-cell tumors (Leivonen et al., 2017), suggesting they could be 
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Figure 1. TCS induces cell death dose-dependently. (A) Molecular structure of TCS. (B) 
BJAB cells were exposed to 10-100 µM for 24 h at 37°C, double-stained with AO/EB to 
distinguish live and dead cells. Cytotoxicity is expressed as the percentage of dead cells 
compared to untreated control cells. (C) Micrographs showing AO and EB uptake by live 
and dead cells, respectively. 
 
Figure 2. TCS stimulates AV and PI uptake. (A) Representative two-dimensional dot 
plots depicting the distribution of control cells treated with the vehicle and those treated 
with 25-75 µM TCS for 24 h at 37°C. (B) Arithmetic means + SEM of AV/PI uptake in 
control and TCS-treated cells. 
 
Figure 3. Effect of TCS on cellular morphology. (A) Representative histogram overlay 
showing FSC of control cells (black line) and those exposed to 75 µM TCS (blue line) for 
24 h at 37°C. (B) Arithmetic means + SEM of FSC in control cells and cells treated with 
25-75 µM TCS. (C) Arithmetic means + SEM of the percentage of cells with reduced FSC 
 
in control and treated groups. (D) Arithmetic means + SEM of the percentage of cells with 
 
increased FSC in control and treated groups. (E) Representative histogram overlay showing 
SSC of control cells (black line) and those exposed to 75 µM TCS (pink line) for 24 h at 
37°C. (F) Arithmetic means + SEM of SSC of control cells and cells treated with 25-75 
µM TCS for 24 h at 37°C. (G) Arithmetic means + SEM of the percentage of cells with 
 
enhanced SSC in control and treated groups. (H) Representative two-dimensional dot plots 
depicting FSC and SSC patterns in control and treated cells. 
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Figure 4. TCS increases intracellular Ca2+ levels. (A) Representative histogram of Fluo3 
fluorescence in control cells (black line) and those treated with 75 µM TCS (orange line) 
for 30 min at 37°C. (B) Arithmetic means + SEM of Fluo3 fluorescence in control cells 
and cells treated with 25-75 µM TCS. (C) Arithmetic means + SEM of the percentage of 
 
cells with increased Fluo3 fluorescence in control and treated groups. (D) Micrographs 
showing Fluo3 fluorescence intensity in control and experimental conditions. (E) 
Representative two-dimensional dot plots of AV/PI uptake in cells treated with 50 µM TCS 
with (orange plot) or without (red plot) 1 h pretreatment with 10 µM BTM. (F) Arithmetic 
means + SEM of the percentage of dead cells in presence and absence of BTM. 
 
Figure 5. TCS causes oxidative stress. (A) Representative histogram of DCF fluorescence 
in control cells (green line) and those treated with 75 µM TCS (brown line) for 30 min at 
37°C. (B) Arithmetic means +SEM of DCF fluorescence in control cells and cells treated 
with 25-75 µM TCS. (C) Arithmetic means + SEM of the percentage of cells with increased 
 
DCF fluorescence in control and treated groups. (D-G) Relative mRNA expression levels 
of antioxidant enzyme genes CAT, SOD, GPX, and GSR in control and TCS-treated cells. 
(H) Representative two-dimensional dot plots of AV/PI uptake in cells treated with 50 µM 
TCS with (turquoise plot) or without (red plot) 1 h pretreatment with 1 mM NAC. (F) 
Arithmetic means + SEM of the percentage of dead cells in presence and absence of NAC. 
 
Figure 6. TCS unbalances BAD and BCL2 gene expression. Relative mRNA expression 
levels of BAD (A) and BCL2 (B) genes in control cells and cells treated with 50 µM TCS 
for 24 h at 37°C. 
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Figure 7. TCS induces genotoxicity. (A) Micrographs of Hoechst fluorescence intensity 
in control and experimental conditions. (B) DNA laddering pattern in control and treated 
cells following electrophoretic migration through 0.75% agarose gel. (C) Relative mRNA 
expression levels of H2AX gene in control cells and those exposed to 50 µM TCS for 24 h 
at 37°C. (D) Relative mRNA expression levels of PARP1 gene in control cells and those 
exposed to 50 µM TCS for 24 h at 37°C. 
 
Figure   8.    Effect   of    small-molecule   inhibitors    on    TCS-induced    cell death. 
 
Representative two-dimensional dot plots of AV/PI uptake and arithmetic means + SEM 
 
of the percentage of dead cells following treatment with 50 µM TCS in absence (red plot) 
and presence of 100 µM zVAD (purple plot; A), 5 µM SB (blue plot; B), 5 µM U0126 (tan 
plot), 5 µM JNK-IN-8 (green plot; D), 100 µM Nec-1 (brown plot; E), or 50 nM NSA (pink 
plot). 
 
Figure 9. A working model for TCS-induced apoptosis in BJAB cells. TCS disrupts 
membrane asymmetry and permeability, elevates cytosolic Ca2+ levels, perturbs redox 
balance, activates caspase and JNK signaling, causing imbalance of Bcl-2 family of 
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Triclosan (TCS) is a broad-spectrum antimicrobial used in personal care products, 
household items, and medical devices. Owing to its apoptotic potential against tumor cells, 
TCS has been proposed for the treatment of malignancy. A major complication of 
chemotherapy is anemia, which may result from direct erythrocyte hemolysis or premature 
cell death known as eryptosis. Similar to nucleated cells, eryptotic cells lose membrane 
asymmetry and Ca2+ regulation, and undergo oxidative stress, shrinkage, and activation of 
a host of kinases. In this report, we sought to examine the hemolytic and eryptotic potential 
of TCS and dissect the underlying mechanistic scenarios involved therein. Hemolysis was 
spectrophotometrically evaluated by the degree of hemoglobin release into the medium. 
Flow cytometry was utilized to detect phosphatidylserine (PS) exposure by annexin-V 
binding, intracellular Ca2+ by Fluo-3/AM fluorescence, and oxidative stress by 2-,7- 
dichlorodihydrofluorescin diacetate (DCFH2-DA). Incubation of cells with 10-100 M 
TCS for 1-4 h induced time- and dose-dependent hemolysis. Moreover, TCS significantly 
increased the percentage of eryptotic cells as evident by PS exposure (significantly 
enhanced annexin-V binding). Interestingly, TCS-induced eryptosis was preceded by 
elevated intracellular Ca2+ levels but was not associated with oxidative stress. Cotreatment 
of erythrocytes with 50 M TCS and 50 M SB203580 (p38 MAPK inhibitor), or 300 M 
necrostatin-1 (receptor-interacting protein 1 (RIP1) inhibitor) significantly ameliorated 
TCS-induced PS externalization. We conclude that TCS is cytotoxic to erythrocytes by 
inducing hemolysis and stimulating premature death at least in part through Ca2+ 
mobilization, and p38 MAPK and RIP1 activation. 




Triclosan (TCS), or 5-chloro-2-(2,4-dichlorophenoxy) phenol, is a broad-spectrum 
antimicrobial extensively used in personal care and hygiene products, clothing and textiles, 
kitchenware, and medical devices (Yueh and Tukey, 2016) (Figure 1A). A recognized 
endocrine disruptor, exposure to TCS may be implicated in a myriad of serious disease 
conditions including immune and thyroid disorders (Clayton et al., 2011). At the cellular 
level, TCS induces cytotoxicity, membrane damage, oxidative stress, and apoptosis (Yueh 
and Tukey, 2016). In particular, the antibacterial and cytotoxic effects of TCS are attributed 
in part to its inhibitory action on de novo fatty acid synthesis by inactivating fatty acid 
synthase (FAS). Because FAS is differentially upregulated in a variety of tumors (Wang et 
al., 2001), TCS along with other FAS inhibitors has been proposed as a promising 
antineoplastic agent against breast, epithelial, and prostatic cancer cells (Sadowski et al., 
2014). 
Owing to widespread exposure in humans, TCS has been shown to accumulate in 
various tissues and body fluids including the brain and blood (Geens et al., 2012). Red 
blood cells (RBCs), also known as erythrocytes, are highly specialized, terminally 
differentiated cells responsible for oxygen delivery and carriage of immune complexes. 
Whereas RBCs have an average lifespan of 100-120 days, various stimuli, including 
xenobiotics, may trigger eryptosis; the suicidal death of erythrocytes. Distinctive features 
of eryptotic cells include cell shrinkage, membrane blebbing, and lipid bilayer scrambling 
leading to phosphatidylserine (PS) externalization to the outer membrane leaflet. Adverse 
conditions that often precede eryptosis include energy depletion, osmotic shock, 
hyperthermia, and oxidative stress (Lang et al., 2012). 
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Accelerated eryptosis constitutes an integral part of the multifaceted 
pathophysiology of a plethora of diseases. These include metabolic syndrome, diabetes 
mellitus, anemia, renal disease, and cancer (Lang and Lang, 2015b; Lang et al., 2017). 
Moreover, the presence of eryptotic cells in the circulation is detrimental because they 
aggravate anemia and adhere to platelets and endothelial cells, giving rise to intravascular 
coagulation and thrombosis (Borst et al., 2012; Walker et al., 2014). Therefore, mature 
erythrocytes have developed an intricate and elaborate machinery to regulate survival and 
senescence. This regulatory network has calcium homeostasis at its core, in addition to 
intracellular mediators such as p38 mitogen-activated protein kinase (MAPK), caspases, 
AMP-activated protein kinase (AMPK), Janus kinase 3 (JAK3), and receptor-interacting 
protein 1 (RIP1), among others (LaRocca et al., 2014; Lang and Lang, 2015a). Cytosolic 
accumulation of calcium eventually leads to membrane scrambling, calpain-dependent 
blebbing, and cell shrinkage following KCl and water loss (Al Mamun Bhuyan et al., 
2017b). Similarly, eryptosis may be initiated through signaling cascades involving either 
the cyclooxygenase-prostaglandin E2 (COX-PGE2) pathway or the stimulation of 
phospholipase 2 (PLA2) and ceramide formation (Lang et al., 2012). 
Despite the revitalized interest in TCS as a cause for concern (Dann and Hontela, 
2011; Yueh and Tukey, 2016), and the prevalence of chemotherapy-induced anemia in 
cancer (Rodgers et al., 2012; Lang et al., 2017), very little emphasis has been placed on 
the interaction of TCS with erythrocytes. Thus, the objective of this study was to 
characterize the hemolytic and eryptotic potential of TCS in this cell type. It was revealed 
that TCS triggers premature cell death through membrane damage, evident as overt 
hemolysis, and loss of membrane asymmetry. Mechanistically, TCS-induced PS exposure 
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was characterized by cytosolic Ca2+ accumulation along with p38 MAPK and RIP1 
stimulation. 
MATERIALS AND METHODS 
 
Erythrocytes, chemicals, and solutions 
 
Fresh, lithium heparin RBC samples from consented, healthy adults were obtained 
from ZenBio (Research Triangle Park, NC, USA). Samples were washed in phosphate- 
buffered saline (PBS; 0.9% NaCl, 1 mM KH2PO4, 5.6  mM Na2HPO4; pH 7.4) at 3,000 
rpm for 10 min at 21C, and TCS exposure was conducted in vitro at 5% hematocrit in 
Ringer solution containing (in mM): 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2- 
hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 glucose, 1 CaCl2; pH 7.4. To 
test for the dependence of TCS-mediated PS exposure on extracellular Ca2+ influx, or 
intracellular Ca2+ availability, cells were incubated in Ca2+-free Ringer solution in which 
CaCl2 was substituted with 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'- 
tetraacetic acid (EGTA) (Chem-Impex Intl., Wood Dale, IL, USA), or were cotreated with 
50 M TCS and 50 M Ca2+ chelator BAPTA-AM. Signaling kinases were evaluated by 
treating the cells to a combination of 50 M TCS and 50 M p38 MAPK inhibitor 
SB203580 (Selleckchem, Houston, TX, USA), 100 M pan-caspase inhibitor z-VAD-fmk 
(Selleckchem), 1 M protein kinase C (PKC) inhibitor Staurosporine (StSp; Cayman 
Chemical Company, Ann Arbor, MI, USA), 100 M casein kinase 1 (CK1) inhibitor 
(D4476; Cayman), 300 M RIP1 inhibitor Necrostatin-1 (Nec-1), or 1 M mixed lineage 
kinase domain-like (MLKL) peudokinase inhibitor Necrosulfonamide (NSA). All 
chemicals were of analytical grade and were purchased from Sigma (St. Louis, MO, USA) 
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unless otherwise noted. An ethanolic stock solution of TCS was prepared at 10 mM and 
diluted to desired concentrations in Ringer solution. 
Hemolysis 
 
RBCs at 5% hematocrit were exposed to 10-100 M of TCS in Ringer solution for 
1, 2, and 4 h at 37C. Following treatment, samples were centrifuged at 13,300 RPM for 1 
min, and the degree of hemoglobin release into the medium was measured by absorbance 
(A) at 405 nm using VersaMax™ ELISA microplate reader (Molecular Devices, San Jose, 
CA, USA). Cells suspended in distilled water constituted 100% hemolysis, and the relative 
percent hemolysis was calculated according to the formula: 
% Hemolysis = (As/Aw) x 100 
 
where As = absorbance of test sample, and Aw = absorbance of positive (distilled water) 
control. 
Detection of PS externalization and forward scatter (FSC) 
 
Following TCS treatment, 50 l of cells were washed in Ringer solution containing 
5 mM CaCl2 and resuspended in a total volume of 200 l. The resulting RBC suspension 
was stained with a 1% v/v solution of Annexin V-FITC (Thermo Fisher Scientific, 
Waltham, MA, USA) for 10 min at room temperature away from light. PS exposure and 
forward scatter FSC were subsequently determined by flow cytometry using a FACScan 
(Betcon Dickinson, Franklin Lakes, NJ, USA) at excitation and emission wavelengths of 
488 nm and 530 nm, respectively. 
Confocal microscopy 
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Control and TCS-treated cells were stained with Annexin-V-FITC as detailed 
above and a homogeneous 20 l cell suspension was spread on a glass slide before it was 
immediately examined with a Zeiss LSM 700 laser scanning microscope (Carl Zeiss 
Microscopy LLC, Thornwood, NY, USA) under a water immersion Plan-Neofluar 40/1.3 
NA DIC objective. 
Determination of intracellular calcium 
 
Cytosolic Ca2+ activity was determined by Fluo3/AM fluorescence (Biotium, 
Fremont, CA, USA). The membrane-permeant Fluo3/AM ester is hydrolyzed 
intracellularly by esterases into Fluo3 whose fluorescence increases upon binding to Ca2+ 
ions, thus serving as an indicator of Ca2+ content. Following TCS treatment, 50 l of cell 
suspension was washed in 5 mM CaCl2 Ringer buffer and incubated with 5 M of 
Fluo3/AM for 30 min at 37C under protection from light. Cells were washed twice to 
remove excess stain, resuspended in 200 l of 5 mM CaCl2 Ringer solution, and finally 
analyzed by a FACScan at 488 nm excitation and 530 nm emission wavelengths. The 
geomean of Fluo3-dependent fluorescence was subsequently determined. 
Measurement of ROS generation 
 
Oxidative stress was assayed by measuring the generation of reactive oxygen 
species (ROS) using the probe 2-,7-dichlorodihydrofluorescin diacetate (DCFH2-DA) 
(Thermo Fisher Scientific, Waltham, MA, USA). DCFH2-DA is a cell-permeant indicator 
that remains non-fluorescent until it is cleaved by intracellular esterases and in turn 
oxidized by ROS into the fluorescent DCF. Following treatment with 50 M TCS, 50 l 
of cell suspension was washed in Ringer buffer, resuspended in a final volume of 200 l, 
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and incubated with 10 M DCFH2-DA for 30 min at 37C in total darkness. DCF 
fluorescence was measured on a FACScan at excitation and emission wavelengths of 488 




Data are shown as arithmetic means + S.E.M. of at least three independent 
 
experiments conducted on RBC samples obtained from three different donors. The Student 
t test was employed to analyze differences among the means, and a value of P < 0.05 was 
defined as the cutoff for statistical significance. n denotes the number of technical 
replicates tested. To control for individual variation and differential susceptibility to 




TCS induces hemolysis time- and dose-dependently 
 
Various xenobiotics have been shown to exhibit a hemolytic activity against human 
RBCs (Lang and Lang, 2015b), and the cytotoxicity of TCS was demonstrated in various 
cell types (Honkisz et al., 2012; Zhang et al., 2015; Park et al., 2016) . To assess the 
hemolytic potential of TCS, erythrocytes were incubated with 10-100 M TCS for 1, 2, 
and 4 h at 37C, and hemoglobin release into the medium was measured as a function of 
cell lysis relative to cells lysed in distilled water. As depicted in Figure 1B, incubation of 
RBCs at the tested concentrations resulted in a dose- and time-dependent increase in 
hemolysis, an effect reaching statistical significance at 25 M following 1 h exposure. This 
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indicates that TCS exerts a hemolytic effect on RBCs that is proportionally related to length 
of exposure time and concentration used. 
TCS causes membrane phospholipid scrambling 
 
Previous studies have demonstrated that TCS induces apoptosis in a variety of 
human cell types including prostatic and placental cells (Sadowski et al., 2014; Zhang et 
al., 2015). In RBCs, among the distinctive features of eryptosis are PS exposure and cell 
shrinkage. To investigate the ability of TCS to stimulate eryptosis, RBCs were incubated 
in Ringer solution containing 10-50 M TCS for 4 h at 37C. Cells were then stained with 
Annexin-V-FITC and analyzed using flow cytometry. Cell size was simultaneously 
estimated from FSC. Our results show that TCS increased PS externalization with a 
statistical significance starting at 25 M (Figure 2A-C). Membrane scrambling was, 
however, not accompanied by alterations in cell volume as indicated by the unchanged FSC 
under control and experimental conditions (Figure 2D & E). Taken together, these data 
suggest that TCS leads to enhanced PS translocation characteristic of eryptotic cells 
without concurrent reduction in cell volume. 
TCS disturbs calcium homeostasis 
 
Membrane scrambling is initiated by increased activity of cytosolic Ca2+ (Lang et 
al., 2012). To test whether Ca2+ accumulation is precedent to PS exposure, cells were 
treated with 10-50 M TCS in Ringer solution for 4 h at 37C, stained with Fluo3/AM, and 
the fluorescence intensity was analyzed by flow cytometry. It was noted that TCS treatment 
induced intracellular Ca2+ levels, an effect attaining statistical significance at 50 M 
(Figure 3). 
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Elevated intracellular Ca2+ may be due to influx into the cell through Ca2+- 
permeable cation channels. To examine whether the increase in cytosolic Ca2+ was due to 
extracellular Ca2+ entry, cells were incubated with or without 50 M TCS for 4 h at 37C 
in Ringer solution or in Ca2+-free Ringer solution, and the ion’s activity was estimated as 
described earlier. As seen in Figure 4, Fluo3 fluorescence was not significantly altered in 
presence or absence of extracellular Ca2+, suggesting that TCS-induced elevated cytosolic 
Ca2+ was not consequent to extracellular influx of the ion. 
Next, we sought to assess the role of Ca2+ in TCS-mediated PS translocation. To 
this end, Annexin-V binding was detected in control and TCS-treated cells in presence and 
absence of extracellular Ca2+, or with and without 50 M BAPTA-AM (a selective Ca2+ 
chelator) for 4 h at 37C. Compared to unaltered Ca2+ conditions, the percentage of cells 
exposing PS was not significantly reduced neither when extracellular Ca2+ was removed 
(Figure 5A-C) nor when intracellular Ca2+ was chelated with BAPTA-AM (Figure 5D-F). 
Thus, preventing extracellular Ca2+ influx or depleting intracellular Ca2+ are apparently not 
required for the full PS-exposing activity of TCS. 
TCS does not induce oxidative stress 
 
The generation of excessive amounts of ROS is a recognized aggravator of 
eryptosis (Lang et al., 2014). We have previously shown that damage associated with TCS 
exposure is in part due to oxidative stress (Yoon et al., 2017). Thus, to test whether TCS- 
mediated PS translocation is preceded by ROS generation, cells were incubated with or 
without 50 M TCS in Ringer solution for 4 h at 37C, and ROS levels were assessed by 
DCF fluorescence using flow cytometry. Figure 6 demonstrates that ROS levels are not 
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significantly changed by TCS treatment, suggesting that TCS-induced eryptosis is not 
mediated through oxidative stress. 
Involvement of kinases 
 
Multiple signaling pathways have been implicated in eryptosis, including p38 
MAPK, caspases, PKC, and CK1 (Lang and Lang, 2015a). RIP1 and MLKL have also been 
recently described, revealing necroptosis as a distinct death pathway in RBCs (LaRocca et 
al., 2014). To identify kinases stimulated in response to TCS exposure, cells were 
incubated in Ringer solution with or without 50 M TCS in presence and absence of 50 
M SB203580 (p38 MAPK inhibitor), 100 M zVAD-fmk (pan-caspase inhibitor), 1 M 
StSp (PKC inhibitor), 100 M D4476 (CK1 inhibitor), 300 M Nec-1 (RIP1 inhibitor), or 
1 M NSA (MLKL inhibitor) for 4 h at 37C. PS translocation was subsequently evaluated 
as previously described. As seen in Figure 7, both SB203580 and Nec-1 significantly but 
not thoroughly blunted PS translocation, while no statistically significant inhibition was 
observed under caspase, PKC, CK1, or MLKL blockage. This identifies p38 MAPK and 




TCS is a high-volume, antimicrobial phenolic compound commonly used as a 
preservative in personal care products, textiles, medical devices, and food contact materials 
(Yueh and Tukey, 2016). Once absorbed, TCS is distributed and deposited in a variety of 
tissues and body fluids, including the liver, brain, and blood. Toxicological profiling of 
TCS has discerned its apoptotic potency in a variety of tumor cells, which could be 
exploited for therapeutic purposes. Thus, complementary to previous studies, this work not 
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only expands on current understanding of TCS toxicity, but also offers assessment of its 
therapeutic potential as an anticancer agent. It is worth mentioning that pathogens whose 
tropism involves the RBC are highly likely to transform infected cells into eryptotic 
corpses, as is the case with Plasmodium spp. (Foller et al., 2009). Thus, elucidating the 
effects of TCS on RBCs becomes more relevant considering that, in addition to its 
antimalarial properties, TCS is known to be effective against important hemoparasites, 
including Babesia, Trypanosoma, Leishmania, and Toxoplasma (Bork et al., 2003; Roberts 
et al., 2003; Otero et al., 2014). 
To the best of our knowledge, this is the first study to report that TCS stimulates 
eryptosis; the suicidal erythrocyte death. TCS elicited hemolysis and eryptosis in 
micromolar concentrations that are lower than the millimolar levels present in consumer 
products, and which are within the range shown to possess antitumor activity (Rodricks et 
al., 2010; Sadowski et al., 2014). It is important to keep in mind that TCS adversaries 
described herein are based on RBCs obtained from healthy individuals. Such findings may 
parallel effects of lower doses in RBCs from cancer patients considering the augmented 
susceptibility of those cells to eryptosis (Lang et al., 2017). Pending in vivo confirmation, 
data from this exploratory study provides evidence of a novel eryptotic sequela of TCS that 
may warrant careful consideration of its use for chemotherapy. 
Similar to findings reported by Miller et al. (Miller and Deinzer, 1980), TCS was 
shown to be highly toxic to erythrocytes causing conspicuous hemolysis indicative of direct 
membrane damage. The lack of ROS generation seems to rule out oxidative stress as a 
contributing factor in TCS-induced hemolysis, as was observed for para-hydroxyanisole, 
and in contrast to bisphenol A (BPA), two related phenolic compounds (Nohl and Stolze, 
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1998; Macczak et al., 2016). Circulating, naked hemoglobin is highly reactive and can 
participate in oxidative damage manifested as perturbations in endothelial cell function, 
hypertension, thrombosis, and atherosclerotic lesions (Miller and Shaklai, 1999; Reiter et 
al., 2002; Studt et al., 2005; Silva et al., 2009). Similarly, extravascular presence of free 
hemoglobin is associated with dysregulated iron homeostasis, renal tubular injury, and 
neuronal damage (Tracz et al., 2007; Lara et al., 2009; Pantopoulos et al., 2012). 
Our data also show that TCS causes a significant increase in eryptotic cells as 
detected by PS externalization, which is in congruence with its apoptotic activity observed 
in nucleated cells (Deepa et al., 2012; Honkisz et al., 2012; Szychowski et al., 2016). 
Several other compounds structurally related to TCS, such as BPA and other 
chlorophenols, have recently been shown to also trigger eryptosis (Macczak et al., 2016; 
Michalowicz et al., 2018). Under physiological conditions, eryptosis may be perceived as 
a counterpoise to erythropoiesis, preventing both anemia and polycythemia. This is because 
exposure of PS serves as a conserved flag on RBCs undergoing eryptosis for recognition 
and removal by the monocyte-macrophage system (Lang et al., 2003), thus acting as a 
safeguard against hemolysis. 
Inordinate eryptosis constitutes a common theme in a variety of life-threatening 
conditions including diabetes, hepatic failure, and malignancy (Lang and Lang, 2015a). In 
these cases and many others, eryptotic cells may adhere to endothelial cells and platelets, 
obstruct microcirculatory flow, and lead to thrombosis (Borst et al., 2012; Walker et al., 
2014). This is a consequence of the negative impact the eryptotic RBC membrane exerts 
on the cell’s deformability and aggregability. When RBCs form larger aggregates with 
rigid membranes, blood viscosity increases, causing enhanced flow resistance, and 
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eventually diminished tissue perfusion (du Plooy et al., 2018; Pretorius, 2018). The limited 
elasticity characteristic of eryptotic membranes may also hinder the cell’s ability to 
reassume its original biconcave shape following passage through the microvasculature 
(Pretorius, 2018). Therefore, identifying the impact of xenobiotics on RBC rheology is 
among the most important aspects of pharmaceutical assessment of potential therapies. 
The importance of Ca2+ activity in mediating eryptosis cannot be overstated, and 
the process has been referred to in the literature as “Ca2+-dependent” programmed cell 
death (LaRocca et al., 2014). Activated K+ channels in response to increased cytosolic Ca2+ 
lead to K+ efflux, membrane hyperpolarization causing Cl- outflow, dehydration due to 
water loss, and eventual cell shrinkage (Lang et al., 2012). Although TCS has been shown 
to cause K+ efflux prior to hemolysis (Miller and Deinzer, 1980), we observed no 
significant change in cell volume among healthy and eryptotic cells despite a significant 
increase in intracellular Ca2+. Likewise, the ionophoric effect of clofazimine was not 
accompanied by cell shrinkage (Officioso et al., 2015). 
Because both scramblase and flippase are Ca2+-sensitive, perturbations in the ion’s 
activity are associated with loss of membrane asymmetry (Lang et al., 2006a). In our study, 
we noted that TCS was able to cause membrane phospholipid scrambling with a significant 
increase in cytosolic Ca2+ at 50 M. This is in consonance with recent findings 
demonstrating Ca2+ dysregulation caused by TCS both in vitro and in vivo (Ahn et al., 
2008; Cherednichenko et al., 2012; Popova et al., 2018). Our data also indicate that neither 
PS exposure nor cytosolic Ca2+ was significantly blunted by Ca2+ depletion, underlining 
the dispensability of the ion in TCS-mediated eryptosis, and pointing at possible additional 
mechanisms. Similar findings were recently reported by Gao et al. for betulinic acid (Gao 
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et al., 2014). Presumably, due to their hydrophobicity, both TCS and betulinic acid may 
readily permeabilize through the membrane to exert their effects (Guillen et al., 2004). On 
the other hand, some xenobiotics such as regorafenib rather depleted intracellular Ca2+ 
while still inducing eryptosis (Zierle et al., 2016). It is important to note that the use of 
EDTA to chelate Ca2+ does not provide total elimination of the ion, which must be taken 
into consideration when evaluating the contribution of extracellular Ca2+ (Al Mamun 
Bhuyan et al., 2017b). 
In RBCs, oxidative stress participates in Ca2+ entry by opening cation channels in 
the cell membrane. We have previously shown that TCS perturbs the antioxidant response 
in human mesenchymal stem cells (Yoon et al., 2017), and oxidative damage by TCS has 
been detected in a variety of cell types (Ma et al., 2013; Szychowski et al., 2016). 
Nevertheless, we found that TCS-induced eryptosis was not accompanied by changes in 
ROS levels. Interestingly, other compounds such as carnosic acid, perifosine, and 
micafungin rather diminished ROS production as part of their eryptotic manifestations 
(Stockinger et al., 2015; Peter et al., 2016c; Egler and Lang, 2017). It is comprehensible to 
surmise that such an event is reflective of a suppressed metabolic rate and cellular 
adaptivity, which is compatible with the anti-inflammatory role of TCS (Barros et al., 
2010). 
The use of small-molecule inhibitors has allowed us to reveal the identity of 
molecular mediators targeted by TCS in erythrocytes. We observed that TCS-induced PS 
exposure was significantly inhibited by blockade of either p38 MAPK or RIP1. Inhibition 
of caspases, PKC, and CK1 provided some degree of protection against PS externalization, 
the extent of which, however, failed to attain statistical significance. Most recently, Zhang 
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et al. demonstrated that TCS promotes p38 phosphorylation in vitro and in vivo (Zhang et 
al., 2018), which is in accord to reports of TCS-induced p38 activation detected in 
Raw264.7 macrophages (Wang et al., 2018a), and rat neural stem cells (Park et al., 2016). 
Whereas p38 is a major orchestrator of eryptosis, RIP1 is known to be critical for 
necroptosis (LaRocca et al., 2014). Nonetheless, RIP1 may also signal for apoptosis, and, 
in fact, acts upstream of p38 MAPK (Lee et al., 2003a). Furthermore, necroptosis is under 
regulation by caspase-8 (LaRocca et al., 2014), adding to the complexity and further 
highlighting the interplay between apoptosis and necroptosis. Therefore, based on the 
identified role of RIP1, we were prompted to probe the involvement of the necroptosis 
executioner, MLKL, in TCS-induced RBC death. The results (Fig. 7G & H) demonstrated 
a lack of significant reduction in PS externalization under MLKL inhibition, thus possibly 
exonerating necroptosis as a mode of cell death. Notably, both pathways were recently 
found to be activated in HepG2 cells in response to Tanshinone IIA, a component of the 
red sage plant Salvia miltiorrhiza (Lin et al., 2016), which also possesses eryptotic activity 
(Zelenak et al., 2012). 
In conclusion, this report shows that TCS adversely affects the physiology and 
survival of RBCs by triggering premature cell death. It was revealed that the integrity of 
the RBC membrane is perturbed by TCS leading to phospholipid scrambling at least in part 
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Fig. 1. TCS induces hemolysis dose and time responsively. A. Chemical structure of 
TCS. B. Arithmetic means ± SEM (n = 9) of RBC hemolysis following incubation for 1-4 
h in Ringer solution without (black bars) or with 10–100 M TCS (grey bars). ns indicates 
not significant; ***(p<0.001) indicates significant difference from control (Student’s t- 
test). 
Fig. 2. Effect of TCS on phosphatidylserine exposure and forward scatter. A. 
Representative histogram showing annexin-V-binding of RBCs incubated for 4 h in Ringer 
solution without (black line) or with (red line) 50 M TCS. B. Arithmetic means ± SEM 
(n = 9) of the percentage of annexin-V-binding RBCs following incubation for 4 h in 
Ringer solution without (black bar) or with 10–50 M TCS (grey bars). C. Confocal 
microscopy images demonstrating control and eryptotic cells with increased FITC 
fluorescence reflective of enhanced PS exposure. D. Representative histogram showing 
erythrocyte FSC after 4 h incubation in Ringer solution without (grey peak) or with (black 
line) 50 M TCS. E. Arithmetic means ± SEM (n = 9) of erythrocyte FSC after 4 h 
incubation without (black bar) or with 10–50 M TCS (grey bars). ns indicates not 
significant; ***(p<0.001) indicates significant difference from control (Student’s t-test). 
Fig. 3. TCS causes intracellular Ca2+ mobilization. A. Representative histogram 
showing Fluo3 fluorescence as a function of cytosolic free Ca2+ in RBCs incubated for 4 h 
in Ringer solution without (black line) or with (brown line) 50 M TCS. B. Arithmetic 
means ± SEM (n = 9) of Fluo3 fluorescence in RBCs following incubation for 4 h in Ringer 
solution without (black bar) or with 10–50 M TCS (grey bars). ns indicates not 
significant; ***(p<0.001) indicate significant difference from control (Student’s t-test). 
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Fig. 4. Effect of extracellular Ca2+ chelation on TCS-induced Ca2+ mobilization. A,B. 
Representative histograms showing Fluo3 fluorescence as a function of cytosolic free Ca2+ 
in RBCs incubated for 4 h without (black line) or with 50 M TCS in presence (brown line, 
A) and absence (yellow line, B) of extracellular Ca2+. C. Arithmetic means ± SEM (n = 9) 
of Fluo3 fluorescence in RBCs following incubation for 4 h without (black bars) or with 
50 M TCS (grey bars) in presence or nominal absence of extracellular Ca2+. ***(p<0.001) 
indicates significant difference from control (Student’s t-test). 
Fig. 5. Effect of extracellular Ca2+ chelation on TCS-induced PS exposure. A,B. 
Representative histograms showing annexin-V-binding RBCs incubated for 4 h without 
(black line) or with 50 M TCS in presence (red line, A) and absence (blush line, B) of 
extracellular Ca2+. C. Arithmetic means ± SEM (n = 9) of the percentage of annexin-V- 
binding cells incubated for 4 h without (black bars) or with 50 M TCS (grey bars) in 
presence and absence of extracellular Ca2+. D,E. Representative histograms showing 
annexin-V-binding RBCs incubated for 4 h without (black line) or with 50 M TCS in 
absence (blue line, D) and presence (sky blue line, E) of 50 M BAPTA-AM. F. Arithmetic 
means ± SEM (n = 9) of the percentage of annexin-V-binding cells incubated for 4 h 
without (black bars) or with 50 M TCS (grey bars) in absence and presence of 50 M 
BAPTA-AM. ***(p<0.001) indicates significant difference from control (Student’s t-test). 
Fig. 6. Effect of TCS on ROS levels. A. Representative histogram showing DCF 
fluorescence after 4 h incubation in Ringer solution without (black line) or with (purple 
line) 50 M TCS. B. Arithmetic means ± SEM (n = 9) of DCF geomean fluorescence after 
4 h incubation without (black bar) or with 50 M TCS (grey bar). ns indicates not 
significant. 
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Fig. 7. TCS-induced phosphatidylserine exposure is suppressed by SB203580 and 
necrostatin-1. A-G Representative histograms showing annexin-V-binding RBCs 
incubated for 4 h without (black line) or with 50 M TCS in absence (red line, A) and 
presence of 50 M SB203580 (blue line, B), 100 M zVAD-fmk (purple line, C), 1 M 
StSp (turquoise line, D), 100 M D4476 (brown line, E), 300 M necrostatin-1 (lime line, 
F), or 1 M NSA (green line, G). H. Arithmetic means ± SEM (n = 3) of the percentage of 
annexin-V-binding cells incubated for 4 h in Ringer solution without (black bar) or with 
50 M TCS (grey bars) in absence and presence of 50 M SB203580, 100 M zVAD-fmk, 
1 M StSp, 100 M D4476, 300 M Nec-1, or 1 M NSA. ns indicates not significant; 
**(p<0.01) and ***(p<0.001) indicate significant difference from TCS-only cells 
(Student’s t-test). 
Fig. 8. A working model for TCS-induced premature erythrocyte death: TCS causes 
calcium ion dysregulation resulting in elevated intracellular Ca2+ activity. Stimulation of 
p38 MAPK and RIP1 signaling in response to TCS culminates in phosphatidylserine 
translocation to the outer membrane leaflet; an event significantly abrogated by 
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Triclosan (TCS) is a phenolic antimicrobial chemical used in consumer products and 
medical devices. Evidence from in vitro and in vivo animal studies has linked TCS to 
numerous health problems, including allergic, cardiovascular, and neurodegenerative 
disease. Using Caenorhabditis elegans as a model system, we here show that short-term 
TCS treatment (LC50: ~0.2 mM) significantly induced mortality in a dose-dependent 
manner. Notably, TCS-induced mortality was dramatically suppressed by co-treatment 
with non-ionic surfactants (NISs: e.g., Tween 20, Tween 80, NP-40, and Triton X-100), 
but not with anionic surfactants (e.g., sodium dodecyl sulfate). To identify the range of 
compounds susceptible to NIS inhibition, other structurally related chemical compounds 
were also examined. Of the compounds tested, only the toxicity of phenolic compounds 
(bisphenol A and benzyl 4-hydroxybenzoic acid) was significantly abrogated by NISs. 
Mechanistic analyses using TCS revealed that NISs appear to interfere with TCS-mediated 
mortality by micellar solubilization. Once internalized, the TCS-micelle complex is 
inefficiently exported in worms lacking PMP-3 (encoding an ATP-binding cassette (ABC) 
transporter) transmembrane protein, resulting in overt toxicity. Since many EDCs and 
surfactants are extensively used in commercial products, findings from this study provide 
valuable insights to devise safer pharmaceutical and nutritional preparations. 
 
KEYWORDS: Caenorhabditis elegans; PMP-3/ABC transporter; endocrine-disrupting 





Endocrine-disrupting chemicals (EDCs) are exogenous compounds that perturb the 
physiology of the endocrine glandular tissue (Swedenborg et al., 2009). These compounds 
can disturb hormone production, release, transport, and metabolism (Kabir et al., 2015). 
Routes of human exposure are varied owing to the wide array of applications and sources 
rich in EDCs. Transdermal absorption from cosmetics and personal hygiene products, 
ingestion in drinking water and food packaging material, and inhalation in dust represent 
the major and most common forms of exposure that carry the greatest risk potential 
(Diamanti-Kandarakis et al., 2009). Furthermore, the developing neuroendocrine tissue of 
neonates is constantly being exposed to high concentrations of EDCs in breast milk and 
infant formula (Fang et al., 2010; Azzouz et al., 2016), incriminating these xenobiotics in 
developmental, neurological, and reproductive anomalies (Schug et al., 2011). 
 
Classification of EDCs is complicated as the number of newly identified, and 
erroneously recognized compounds, continues to steadily grow. Although many remain 
insufficiently characterized, phenolic EDCs are among the most common and well-studied 
classes. A prominent example is triclosan (TCS); an antimicrobial extensively used in the 
manufacture of plastics, toys, cosmetics, and kitchenware (Figure 1A). TCS has also been 
used for decades in hospital settings as an antiseptic and a disinfectant (Rodricks et al., 
2010; Dann and Hontela, 2011). The antimicrobial activity of TCS is attributed to the 
compound’s interference with the enzyme enoyl-acyl carrier protein reductase (FabI), 
which is required for fatty acid and biotin biosynthesis (Rodricks et al., 2010). Beside its 
antimicrobial properties, TCS toxicity has been studied in various living systems including 
humans, and the chemical has been shown to build up in body fluids including blood, urine, 
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and breast milk (Fang et al., 2010; Rodricks et al., 2010). Due to its widespread use and 
high chlorine content, TCS and its derivatives are ubiquitous in soil and aquatic 
environments, and have been detected in wastewater treatment systems as well as drinking 
water sources (McAvoy et al., 2002; Escalada et al., 2005; Benotti et al., 2009; Li et al., 
2010). 
 
The nematode Caenorhabditis elegans (C. elegans) has emerged as an attractive 
model animal for the functional analysis of various bioactive compounds (Tejeda-Benitez 
and Olivero-Verbel, 2016; Honnen, 2017; Hunt, 2017). Recent reports have shown that 
TCS exposure reduced the viability and fertility of wild-type C. elegans worms in a dose- 
dependent manner (Lenz et al., 2017; Yoon et al., 2017; Garcia-Espineira et al., 2018; 
Vingskes and Spann, 2018). To date, although significant progress has been made in our 
understanding of TCS toxicity, studies devoted to the identification of clinically or 
industrially relevant TCS inhibitors are extremely scarce. In this study, we demonstrate 
that non-ionic surfactants (NISs), such as Tween 20 (Tw20), Tween 80 (Tw80), NP-40, 
and Triton X-100 (TX100), act as potent antagonists of phenolic EDCs including TCS, 
bisphenol A (BPA), and benzyl 4-hydroxybenzoic acid (B4HB). Mechanistic analyses 
revealed that NISs inhibit TCS-induced mortality by micellar solubilization, and that 
internalized TCS-micelle complex appears to be exported by PMP-3 (encoding an ATP- 
binding cassette (ABC) transporter) protein. Given the concerns surrounding TCS 
exposure, our findings may provide an innovative approach to reduce the burden of TCS 




Chemicals and reagents 
 
All chemicals used in this study were purchased from Sigma Aldrich (MO, USA) 
and were of analytical grade. TCS and benzyl 4-hydroxybenzoic acid (B4HB) were 
prepared in ethanol as 0.1 M stock solutions. Bisphenol A (BPA) was dissolved in 
methanol to obtain a 0.1 M stock solution, while 0.1 M stock solutions of sodium dodecyl 
sulfate (SDS) and sodium azide (NaN3) were made in distilled water. 
 
 
Strains and maintenance 
 
C. elegans wild-type Bristol isolate (N2) and pmp-3(ok1087) mutant worms were 
obtained from the Caenorhabditis Genetics Center (CGC). All strains were cultured at 20°C 





Embryos were obtained by sodium hypochlorite (0.5 M NaOH and 1.2% NaClO) 
treatment of gravid hermaphrodites and incubated in M9 buffer (22 mM KH2PO4, 42 mM 
Na2HPO, 86 mM NaCl, and 1 mM MgSO4) at 20
°C overnight, as described elsewhere 
(Yoon et al., 2016). Hatched L1 animals were either exposed to toxicants or were allowed 
to grow to adults on NGM plates for 3 days at 20°C before exposure. All chemicals were 
diluted in either M9 or M9/0.1% NISs to the final testing concentrations. Treatment groups 
were compared to the vehicle control, which did not exceed 0.2% in each case. The 
mortality rate was calculated visually by counting live and dead worms using a bright field 
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microscope (Figure 1B). Live worms exhibited normal locomotive behavior (Figure 1C), 
whereas dead worms were nonmotile and appeared rod-like in shape (Figure 1D). 
 
 
Antimicrobial susceptibility testing 
 
E. coli OP50 bacteria were grown at 37°C for 5 hours in Lysogeny Broth (LB) 
medium. Exposure was conducted in the same medium supplemented with TCS ranging 
from 0.001 mM to 0.05 mM with or without 0.1% Tween 20 (Tw20) for 24 hours at 25°C. 
The optical density (OD600) was measured spectrophotometrically every two hours as an 
indicator of bacterial growth. 
 
 
Pharyngeal pumping rate 
 
Wild-type adult worms were incubated for 1 hour at 25°C in M9 buffer with or 
without 0.1% Tw20, before they were plated on NGM and examined for pumping using a 
dissecting microscope. Grinder movements were monitored for one minute, and the 
number of pumps per minute (ppm) was recorded. 
 
 
Disruption of intracellular micelles 
 
NIS Micelles were heat-disrupted at 35°C. Following TCS treatment with or 
without 0.1% Tw20, two approaches were followed for micelle disruption (Figure 4A). In 
method I, worms were immediately incubated at 35°C for an additional hour, whereas in 
method II, removal of extracellular TCS-Tw20 complexes by sequential washing in M9 




Results are expressed as arithmetic means  SD of at least three independent 
replicates (n>300). Comparative assessments between control and treatment groups were 
conducted using the paired t-student test. Statistical significance was determined by a p 




TCS increases mortality dose-dependently 
 
Amongst phenolic EDCs, we initially investigated TCS due to its widespread 
occurrence and well-documented toxicity (Rodricks et al., 2010). In eukaryotes, TCS 
disrupts mitochondrial oxidative phosphorylation and leads to profound increase reactive 
oxygen species (ROS) (Weatherly et al., 2016). We recently reported that TCS induces 
toxicity, at least in part, by disrupting SKN-1(SKiNhead-1)/NRF2 (erythroid-2-related 
factor 2)-mediated oxidative stress response in both C. elegans and human stem cells 
(Yoon et al., 2017). 
 
To initially determine the effect of TCS on C. elegans viability, synchronized L1 
larvae were treated with varying concentrations of TCS (0, 0.125, 0.25, 0.5, 1, 2, and 4 
mM) for 1 hour at 25C. As shown in Figure 1E, the mortality rate of L1 worms increased 
in a dose-dependent manner with a TCS concentration of half maximal response (EC50) of 
~ 0.2 mM. A similar dose-dependent pattern of increased mortality was also observed in 
adult worms (Figure 1F). These results suggest that TCS significantly increased the 
mortality of wild-type (N2) worms in a dose-dependent manner. 
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NISs abrogate TCS-induced mortality 
 
Hydrophobic substances can be emulsified in micelles formed by NISs such as 
Tw20 (Lu and Park, 2013), and the benzene ring in TCS imparts a hydrophobic nature to 
the antiseptic (Petersen, 2016). To test the hypothesis that TCS-induced mortality could be 
neutralized by NISs, both L1 larvae and adult worms were treated with 0.125-8 mM TCS 
in presence or absence of 0.1% Tw20 for 1 hour at 25C, and the mortality rate of both 
groups was calculated. Interestingly, co-treatment of TCS and Tw20 led to a profound 
decrease in the mortality of both stages when compared to TCS alone (Figure 2A and S1A). 
The highest TCS concentration susceptible to 0.1% Tw20 was around 8 mM and 4 mM for 
L1 larvae and adult worms, respectively (Figure 2A and S1A). 
 
To determine the minimum effective concentration of Tw20 required to confer 
protection against lethal concentrations of TCS, L1 larvae were incubated for 1 hour with 
1, 2, and 4 mM TCS in the absence or presence of 0.1, 0.02, 0.004, and 0.0008% Tw20. 
As for L1 larvae, at least 0.02% Tw20 was sufficient to protect against 4 mM TCS, while 
0.004% Tw20 was sufficient against 1 mM TCS (Figure 2C). Parallel to L1 larvae, the 
mortality rate of adult worms at 1 and 2 mM TCS was significantly abrogated with at least 
0.004% and 0.02% Tw20, respectively (Figure S1B). 
 
Next, we were prompted to test the effects of other NISs, including Tw80, NP-40, 
and TX100 on TCS-induced mortality. To this end, L1 staged wild-type worms were 
incubated with or without 0.5 mM TCS (minimum concentration with >80% mortality) in 
the absence or presence of 0.1-0.0008% Tw80, NP-40, or TX100 for 1 hour at 25C, and 
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the mortality rate was calculated as described earlier. As seen in Figure 2E, all NISs 
significantly protected the worms against 0.5 mM TCS dose-dependently. 
 
In industrial settings, anionic surfactants such as sodium dodecyl sulfate (SDS) are 
also added to commercial products to solubilize TCS (Babich and Babich, 1997). In order 
to determine if SDS is also capable of antagonizing TCS toxicity, we incubated L1 larvae 
with 0.5 mM TCS in the presence of 1, 10, and 20 mM SDS for 1 hour at 25C and scored 
the mortality rate as outlined before. Figure 2E shows the wormicidal activity of SDS at 
10 and 20 mM, and, more importantly, the failure of SDS at 1 mM to protect against TCS- 
induced mortality. Collectively, these observations suggest that TCS-induced mortality is 
abrogated by co-treatment of NISs (i.e. Tw20, Tw80, NP-40, and TX100), but not by SDS. 
 
We then sought to inquire whether Tw20 could also neutralize the antimicrobial 
activity of TCS. To this end, E. coli bacteria were cultured with or without 0.001-0.2 mM 
TCS in the absence or presence of 0.1% Tw20 for 24 hours at 25°C. We specifically 
cultured E. coli bacteria at 25°C, instead of 37°C, to preserve the micellar state of Tw20. 
Optical density at 2-hour intervals was measured as a function of bacterial growth. 
Although TCS unsurprisingly inhibited bacterial growth at all concentrations tested, 
significant resistance was observed under conditions of a combination of 0.001 mM TCS 
and 0.1% Tw20 (Figure 2D, compare (3) and (7)). These findings suggest that the 
inhibitory action of NISs against TCS is also observed in bacteria. 
 
Ingestion in C. elegans is accomplished through the pharynx and requires two 
sequential events; pumping and peristalsis. Pharyngeal movement is related to food intake, 
and is influenced by environmental conditions in the immediate vicinity of the worm (Song 
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and Avery, 2013). Thus, we examined if the protective role of Tw20 is related to restricted 
pharyngeal pumping, which would hinder TCS uptake. To this end, adults were exposed 
to 0.1% Tw20 or left untreated for 1 hour at 25°C. Worms were then plated and grinder 
movements (number of pumps per minute) were recorded under a differential interference 
contrast (DIC) microscope. Our results showed no significant difference in the rate of 
pharyngeal pumping in presence or absence of Tw20 (Figure 2B), which indicates that 
Tw20 does not neutralize TCS toxicity by reducing its physical intake. 
 
NISs mitigate the mortality induced by other phenolic EDCs: BPA and B4HB 
 
To assess the range of compounds sensitive to NIS interference, we tested the effect 
of NISs on other toxicants that are not recognized as EDCs (Figure 3A, left). Sodium azide 
(NaN3) is a polar, ionic salt commonly used as a solution preservative owing to its biocidal 
properties (Ishikawa et al., 2006). It interferes with mitochondrial oxidative 
phosphorylation by chelating iron ions required for cytochrome oxidase activity (Ishikawa 
et al., 2006). We evaluated the ability of NISs to subvert sodium azide toxicity by 
incubating L1 larvae with or without 0.2-1.6 mM sodium azide in the absence or presence 
of 0.1% NISs for 24 hours at 25°C. Figure 3B shows that the dose-responsive increase in 
mortality was not nullified by co-treatment with NISs. Ethanol (EtOH) is another polar 
compound with disruptive behavioral effects on C. elegans (Davies et al., 2004) (Figure 
3A, left). To test whether NISs could protect against EtOH mortality, L1 larvae were 
incubated with or without 10%-20% EtOH in the absence or presence of 0.1% NISs for 1 
hour at 25°C, and the mortality rate was subsequently scored. Our data show that 20% 
EtOH resulted in 100% mortality in wild-type worms which was not reversed by co- 
treatment with 0.1% NISs (Figure 3C). 
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Although we cannot exclude all other possibilities, these results indicate that 
molecular similarity among compounds may be a determining factor in their susceptibility 
to NISs. Hence, we examined two other chemicals that are closely related to TCS in terms 
of both their chemical nature (a common phenol ring) and activity (endocrine disruption) 
– BPA and B4HB (Figure 3A, right). The xenoestrogenic activity of BPA is associated 
with increased proliferation of ovarian and breast cancer cells (Dong et al., 2011), 
genotoxicity (Pupo et al., 2012), and elevated prolactin, estradiol, and progesterone levels 
in females (Miao et al., 2015). B4HB is a paraben widely used as a preservative in 
cosmetics and food processing (Ye et al., 2006). Exposure to parabens has been strongly 
linked to human health concerns mainly due to their estrogenicity and proliferative 
stimulation of breast cancer cells (Byford et al., 2002). Moreover, butylparaben has been 
shown to cause DNA damage in human sperm (Meeker et al., 2011). 
 
To test if NISs could protect against BPA-induced mortality, L1 larvae were 
incubated with or without 0.5-2.0 mM BPA in presence and absence of 0.1% NISs for 24 
hours at 25°C. In agreement with previous reports (Watanabe et al., 2005), BPA caused a 
dose-dependent increase in mortality, and, interestingly, co-treatment with 0.1% NISs 
significantly ablated BPA-induced mortality (Figure 3D). We also determined the 
wormicidal potential of B4HB and its sensitivity to NIS inhibition. To this end, L1 larvae 
were incubated with or without 0.25-1.0 mM B4HB in the absence or presence of 0.1% 
NISs for 1 hour at 25°C. As shown in Figure 3E, B4HB resulted in a significant, dose- 
dependent increase in mortality at all concentrations tested. Importantly, a similar pattern 
of inhibition to TCS and BPA was also observed in worms co-treated with B4HB and NISs 
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(Figure 3E). Taken together, these results suggest that NISs may protect against phenolic 
EDCs that share structural similarity to TCS. 
 
Micellar solubilization is required for NIS-mediated protection 
 
We next tested if NISs could inhibit the toxicity of TCS via micelle formation. 
Tw20 was chosen as a representative NIS as it showed potent inhibitory action against TCS 
concentrations with 100% mortality (Figure 2A). To this end, L1 larvae were incubated 
with or without 1 mM TCS in the absence or presence of 0.1% Tw20 for 1 hour at 25C 
(Figure 4A). As observed earlier, 1 mM TCS resulted in 100% mortality, which was 
reversed by co-treatment with 0.1% Tw20 (Figure 4B, Pre-incubation). 
 
To evaluate the importance of micellar solubilization for the anti-toxic activity of 
Tw20, micelles were heat-disrupted by upshifting exposure temperature to 35C 
(Markovic-Housley and Garavito, 1986) for an additional hour (Figure 4A, Method (I)). 
Notably, the mortality of worms co-treated with TCS and Tw20 significantly increased 
following the temperature upshift (Figure 4C, Method (I)). This seems to indicate that 
sequestered TCS molecules within Tw20 micelles were released upon temperature- 
mediated micelle disruption and regained their wormicidal activity. Furthermore, to rule 
out the contribution of extracellular TCS in the observed mortality following the upshift, 
extracellular TCS-Tw20 complexes were removed by repeated washing and L1 larvae were 
then upshifted to 35C for an additional hour (Figure 4A, Method (II)). Under these 
conditions, up to ~ 30% increase in mortality in comparison to Tw20-treated worms (Figure 
4C, Method (II)) was observed, which is attributed mostly to the internalized TCS-Tw20 
complexes. 
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The PMP-3/ABC transporter modulates the absorption, metabolism, and 
cytotoxicity of pharmacological agents (Das et al., 2006). Of recent, we have reported that 
lack of PMP-3 increases susceptibility to TCS (Yoon et al., 2017). A reporter gene analysis 
showed that pmp-3 (promoter)::GFP is expressed in the pharynx, muscles, intestine, and 
stem cell niche (Figure S2). To ask if internalized TCS-Tw20 micelle complexes are 
exported out of the worms’ bodies through PMP-3, L1 stage pmp-3(ok1087) loss-of- 
function mutant worms (pmp-3(-)) were treated as described in Figure 4A. As is the case 
with wild-type worms (Figure 4B), 1 mM TCS caused 100% mortality in pmp-3(-) mutants, 
which was significantly ameliorated in the presence of 0.1% Tw20 (Figure 4D, Pre- 
incubation). Importantly, the mortality of pmp-3(-) mutants was significantly enhanced 
following heat-mediated micelle disruption, an effect that was significantly higher than that 
of their wild-type counterparts (p<0.01, compare Figure 4C and 4E, Method (I)). 
 
Next, to test if accumulated intracellular TCS could increase the mortality in pmp- 
3(-) mutant worms, we co-treated L1 staged pmp-3(-) mutant worms with 1 mM TCS and 
0.1% Tw20 for 1 hour at 25C, before the temperature was upshifted to 35C following 
washing for three times (Figure 4A, Method (II)). Interestingly, TCS molecules released 
from Tw20 micelles at 35C significantly increased the mortality (76 ± 3.7%) of pmp-3(-) 
mutant worms more than that (34 ± 3.6%) seen in wild-type worms (p<0.01, compare 
Method(II) in Figure 4C and 4E). 
 
Taken together, these results point at two possible conclusions: First, Tw20 may 
inhibit the wormicidal properties of TCS by micellar solubilization. Second, export of 
internalized TCS-Tw20 micellar complex may be facilitated, at least in part, through PMP- 
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3-mediated detoxification mechanism. Although only TCS was evaluated under these 
conditions, it is reasonable to suggest that a similar pattern is likely mirrored by other 




EDCs are ubiquitous in the environment and pose a global threat to human and 
wildlife health. To date, studies elucidating the toxicity of EDCs have received greater 
attention from researchers, while investigations devoted to the identification of EDC 
inhibitors are only recently emerging. For instance, just a few years ago, Sengupta et al. 
reported that atrazine inhibits TCS toxicity by activating the nuclear receptor HR96 (an 
ortholog of CAR/PXP/VDR) in Daphnia magna (Sengupta et al., 2015). In addition, the 
interaction of surfactants with other antibacterials such as amoxicillin and moxifloxacin 
has previously been examined (Schwameis et al., 2013). However, no studies have 
investigated the protective role of NISs against EDC toxicity in eukaryotic model systems. 
 
This work establishes the nematode C. elegans as a model for studying the toxicity 
of phenolic EDCs, and also demonstrates the potent ameliorative potential of NISs against 
the wormicidal properties of TCS and other phenolic EDCs, facilitated through micellar 
solubilization. The TCS-micelle complex appears to be exported out of the worms’ bodies 
at least in part through a PMP-3/ABC transporter (Figure 5A and 5B). However, following 
micelle disruption, released TCS seems to regain its activity and in turn perturbs the 
survival of worms (Figure 5C). In pharmaceutical and nutritional preparations, NISs have 
been used as solubilizers and stabilizers, but their potential effects on the detoxification of 
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EDCs have largely been overlooked. Therefore, our findings present broad insights into 
EDC intoxication, detoxification, and product formulation strategies. 
 
The activity of phenolic compounds is influenced by their percent saturation in 
solution (Ogata and Shibata, 2000). Micelle aggregates are formed when surfactants are 
dissolved in solutions at or above their critical micelle concentration (CMC). Surfactants 
can solubilize phenolics in the micellar phase and thus reduce their thermodynamic activity 
(Allawala and Riegelman, 1953). To put things into perspective, a saturated water solution 
of chloroxylenol, a phenolic disinfectant, was shown to exhibit comparable biocidal 
efficacy to a saturated surfactant solution with concentrations of many orders of magnitude 
higher (Mitchell, 1964). Moreover, Taylor et al. compared the efficacy of TCS against E. 
coli at 100% saturation in ammonium lauryl sulfate (ALS) solutions of varying 
concentrations (Taylor et al., 2004). Interestingly, the degree of bacterial growth reduction 
when ALS was increased was similar to that observed when less ALS and twice as much 
TCS were used (Taylor et al., 2004). This indicates that surfactant to EDC ratio, but not 
EDC concentration, determines the overall fate of EDC activity. Similarly, other phenolic 
antimicrobial agents, most notably rifampicin and isoeugenol, were found to be highly 
susceptible to inactivation by Tw80 (Nielsen et al., 2016). In E. coli, our data show that 
TCS retains its antibacterial activity at a minimum concentration of 0.001 mM when co- 
administered with 0.1% Tw20, suggesting that the bioavailable portion of TCS was 
sufficient to exhibit its bactericidal effect under these saturation conditions (see Figure 2D). 
This is corroborated by the contrasting synergistic effect of Tw80 on water-soluble 
antimicrobials such as polymyxin B and benzalkonium chloride (Toutain-Kidd et al., 
2009). It is important to note that, because TCS inhibits the synthesis of fatty acids, which 
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are abundant in surfactants, it has been surmised that TCS-resistant Staphylococcus aureus 
compensate for the anti-lipogenic effect of TCS by utilizing exogenous fatty acids 
presumably provided by the Tween surfactants (Morvan et al., 2016). In C. elegans, 
manipulating the NIS-TCS ratio showed that NISs are potent inhibitors of phenolic EDCs 
at very low concentrations. Our results revealed that NIS concentrations as low as 0.0008% 
significantly reduced the mortality caused by a lethal TCS dose of 0.5 mM (see Figure 2C). 
This remarkable inhibitory efficiency, compared to that seen in E. coli, could be ascribed 
to the outer cuticle that encapsulates the worms and imparts environmental and anti-toxic 
protection. 
 
In conclusion, the current study identifies NISs as potent inhibitors of phenolic 
EDCs in an eukaryotic model organism. The findings presented herein may pave the way 
for devising and developing potentially effective preventive and therapeutic strategies to 
control the widespread dissemination of phenolic EDCs, while still maintaining their 
beneficial antimicrobial properties. The observations presented here, along with those from 
previous studies, mandate further investigations based on a multidisciplinary approach, 
combining physicochemical and biological aspects, to fully characterize the direct 
interaction between NISs and EDCs. Future efforts should be directed toward investigating 
the complex interplay between NIS solubilization and its net effect on drug digestion, 
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Figure 1. TCS induces mortality of wild-type worms. (A) Chemical structure of TCS. 
 
(B) Strategy for chemical treatment. (C and D) DIC pictures of wild-type worms in the 
absence or presence of TCS. (E) Percent mortality in TCS-treated wild-type L1 larvae. 
Standard deviation bars were calculated from at least three independent experiments 
(n>300). p<0.05(*); p<0.01(**); p<0.001(***); Not statistically significant (n.s.). 
 
Figure 2. Protective role of NISs against TCS. (A) Effect of Tw20 on TCS-induced 
mortality in L1 larvae. (B) Effect of Tw20 on pharyngeal pumping. (C) Dose-dependence 
effect of TCS and Tw20 on mortality. (D) Effect of Tw20 on the antimicrobial activity of 
TCS. (E) Effect of NISs on TCS-induced mortality. Standard deviation bars were 
calculated from at least three independent experiments (n>300). p<0.05(*); p<0.01(**); 
p<0.001(***); Not statistically significant (n.s.). 
 
Figure 3. NISs suppress the mortality induced by other phenolic EDCs. (A) Chemical 
structures of non-EDCs and phenolic EDCs. (B-E) Effect of NISs on toxicant-induced 
mortality. For NaN3 and BPA, total exposure period was 24 hours at 25
°C. For EtOH and 
B4HB, worms were treated for 1 hour at 25°C. Standard deviation bars were calculated 
from at least three independent experiments (n>300). p<0.05(*); p<0.01(**); 
p<0.001(***); Not statistically significant (n.s.). 
 
Figure 4. Tw20 inhibits TCS-induced mortality via micelle formation. (A) Exposure 
strategy. (B & C) Effect of Tw20 micelle formation on TCS-induced mortality in wild-type 
worms. (D & E) Role of PMP-3 in the export of TCS-Tw20 micellar complex. Standard 
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deviation bars were calculated from at least three independent experiments (n>300). 
 
p<0.05(*); p<0.01(**); p<0.001(***); Not statistically significant (n.s.). 
 
Figure 5. A working model for NIS amelioration of EDC-induced mortality. (A) EDCs 
can act via receptor-based mechanism, but at high doses, EDCs may employ receptor- 
independent mechanisms. EDCs (e.g., TCS) may also inhibit PMP-3-mediated 
detoxification mechanisms (Yoon et al., 2017). (B) EDCs could be inactivated in vivo by 
NIS-mediated micellar solubilization and the EDC-NIS complex may be exported at least 
in part by PMP-3/ABC transporters. (C) Upon micelle disruption, liberated EDC molecules 
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N,N-Diethyl-3-methylbenzamide (DEET) is the most widely used insect repellent in the 
world. Adverse effects following DEET exposure are well documented. Moreover, DEET 
has been shown to possess cytotoxic and apoptotic properties in nucleated cells. Although 
red blood cells (RBCs) lack intracellular organelles, they nevertheless undergo 
programmed cell death termed eryptosis. Compromised RBC health contributes to the 
development of anemia; a condition affecting 25% of the global population. This study 
investigated the interaction between DEET and human RBCs, and explored accompanying 
biochemical and molecular alterations. RBCs at 5% hematocrit were incubated in presence 
and absence of 1-5 mM (0.02%-0.1%) of DEET for 6 h at 37°C. Hemolysis was 
spectrophotometrically determined by hemoglobin release, while major eryptotic events 
were analyzed by flow cytometer. Phosphatidylserine (PS) exposure was detected with 
Annexin-V-FITC, cell volume by forward scatter (FSC) of light, intracellular calcium with 
Fluo-3/AM, and reactive oxygen species with 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA). DEET caused slight hemolysis at 4 and 5 mM, and significantly increased 
Annexin-V-FITC and Fluo3 fluorescence, with reduced FSC at 5 mM. Removal of 
extracellular Ca2+ abolished DEET-induced Fluo3 fluorescence but had no effect on 
Annexin-V binding. Importantly, blockade of eryptotic signaling mediators p38 MAPK, 
caspases, protein kinase C, casein kinase 1, or necroptotic kinases receptor-interacting 
protein 1 and mixed lineage kinase domain-like protein, with small molecule inhibitors, 
did not ameliorate DEET-mediated PS externalization. In conclusion, DEET elicits suicidal 
erythrocyte death; an event characterized by loss of membrane asymmetry, cell shrinkage, 
and elevations in intracellular Ca2+ mainly through dysregulated Ca2+ influx. 
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The World Health Organization (WHO) reports that a little less than one-fifth of the 
global burden of infections is caused by vector-borne disease, which accounts for around 
700,000 deaths annually (WHO. Global vector control response 2017–2030. Geneva: 
World Health Organization;  2017. 
http://apps.who.int/iris/bitstream/handle/10665/259205/9789241512978- 
eng.pdf?sequence=1). Among the most infamous vectors are mosquitoes in the Anopheles, 
Aedes, and Culex genera. These blood-sucking insects are responsible for the transmission 
of serious diseases and pathogens including malaria, filariasis, yellow fever, dengue fever, 
chikungunya, Zika virus, West Nile virus, Japanese encephalitis, and St. Louis encephalitis 
(WHO. Vector-borne diseases: Report of an informal expert consultation. New Delhi: 
World Health Organization;  2014. 
http://apps.who.int/iris/bitstream/handle/10665/206531/B5139.pdf?sequence=1; WHO: 
Yellow fever fact sheet. http://www.who.int/en/news-room/fact-sheets/detail/yellow- 
fever) (Mackenzie et al., 2004; Mulatier et al., 2018). Given the lack of vaccination, 
prophylaxis by insect repellents remains one of the most efficient and widely used methods 
to prevent the spread of vector-borne disease worldwide. 
N,N-Diethyl-3-methylbenzamide (DEET) is the most commonly used insect repellent 
in the world (Fig. 1A) (Chen-Hussey et al., 2014). Since its introduction over half a century 
ago (Nentwig, 2003), DEET has demonstrated efficacy in reducing the transmission of 
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vector-borne disease. The repellence properties of DEET may be attributed to its activation 
of olfactory receptor neurons (ORNs) in mosquito antennae, among other possible 
mechanisms (Leal, 2014). Products containing up to 100% DEET are available to 
consumers in a variety of formulations including sprays, aerosols, gels, lotions, sticks, and 
wipes (Diaz, 2016). 
Pharmacokinetic studies in animals indicate significant variability in oral and dermal 
absorption of DEET. In humans, although absorption rates may reach as high as 20%, 
extensive variations observed in animals may still be mirrored in man (Feldmann and 
Maibach, 1970; Blomquist and Thorsell, 1977; Reifenrath et al., 1980; Reifenrath et al., 
1981; Snodgrass et al., 1982; Moody et al., 1989; Moody and Nadeau, 1993; Taylor et al., 
1994; Selim et al., 1995). DEET reaches the systemic circulation, crosses the placenta 
(McGready et al., 2001; Barr et al., 2010; Diaz, 2016), and is chiefly eliminated in the 
urine. Major DEET metabolites excreted are N,N-diethyl-mhydroxymethylbenzamide and 
N-ethyl-m-hydroxymethylbenzamide, representing up to 42% of applied dose (Selim et al., 
1995). The unchanged parent compound has also been detected in urine (Smallwood et al., 
1992). Nevertheless, based on the inherent diversity of human use and consumption, 
variations in DEET bioavailability and metabolism are expected to be not uncommon. 
Intoxication related to DEET is well documented in animals and humans, with dermal, 
neurologic, ocular, psychotic, respiratory, gastrointestinal, and cardiovascular 
manifestations (Heick et al., 1980; Snyder et al., 1986; Heick et al., 1988; McKinlay et al., 
1998; Briassoulis et al., 2001; Bell et al., 2002; Jortner, 2006). Cases of accidental and 
suicidal death have also been reported following oral and dermal exposure to DEET (Veltri 
et al., 1994; Bell et al., 2002; Wiles et al., 2014). Populations at higher risk of adverse 
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DEET effects include children, workers in parks and manufacturing plants, and individuals 
with preexisting skin conditions (https://www.atsdr.cdc.gov/toxprofiles/tp185.pdf; 
https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+1582). To 
date, there exists a paucity in the literature concerning the cellular and molecular effects of 
DEET, and the potential toxic effects of the repellent on human red blood cell (RBC; 
erythrocyte) lifespan have not yet been reported. Responsible for gas exchange and transfer 
of immune complexes, RBCs have a lifespan of 120 days, after which they are removed 
from the circulation by the monocyte-macrophage system (Lang and Lang, 2015b). 
Although they lack intracellular organelles, most notably the nucleus and mitochondria, 
RBCs nonetheless undergo a specific form of programmed cell death known as eryptosis. 
Characteristics of eryptotic cells include membrane blebbing and phospholipid scrambling, 
cell shrinkage, intracellular accumulation of calcium and reactive oxygen species (ROS), 
ceramide formation, and energy exhaustion (Lang et al., 2012). As in apoptosis of 
nucleated cells, multiple signaling mediators similarly regulate eryptosis. Although still in 
their infancy, discovery efforts have discerned the existence of caspases, p38 mitogen- 
activated protein kinase (MAPK), casein kinase 1 (CK1), protein kinase C (PKC), receptor- 
interacting protein 1 (RIP1), mixed lineage kinase domain-like protein (MLKL), Janus 
kinase 3 (JAK3), 5' AMP-activated protein kinase (AMPK), and cGMP-dependent protein 
kinase (cGKI), (Lang et al., 2012; LaRocca et al., 2014; Lang and Lang, 2015b). 
Various xenobiotics and pathological conditions have been identified as modulators of 
eryptosis (Pretorius et al., 2016) and the effect of DEET on RBC lifespan remains an 
uncharted territory. In this report, we sought to investigate the interaction between DEET 
and human RBCs, which represent an excellent model to assess the toxicity of xenobiotics 
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(Hinderling, 1997; Schrijvers, 2003; Farag and Alagawany, 2018). Here, we show that 
DEET causes premature RBC death characterized by loss of membrane asymmetry and 
phosphatidylserine (PS) externalization, profound intracellular calcium accumulation 
secondary to dysregulated influx, and cell shrinkage. Interestingly, the eryptotic effects of 
DEET were not mediated through oxidative stress, did not depend on calcium availability, 
and are not significantly ameliorated by blocking of major cell death signaling pathways. 
 
 
MATERIALS AND METHODS 
 
Erythrocytes, chemicals, and solutions 
 
Fresh, citrate-phosphate-dextrose-adenine (CPDA-1)-anticoagulated RBC samples 
from consented, healthy adults were obtained from ZenBio (Research Triangle Park, NC, 
USA). Samples were stored at 40C according to standard blood banking procedures 
(Fernandes da Cunha et al., 2005) and used within 20 days of collection. Cell viability 
and validity for experimentation was verified by low (<5%) Annexin-V-FITC binding 
(Lupescu et al., 2014). Prior to experiments, RBCs were washed in phosphate-buffered 
saline (PBS; 0.9% NaCl, 1 mM KH2PO4, 5.6 mM Na2HPO4; pH 7.4) at 2500 rpm for 15 
min at 21°C, and were then incubated at 5% hematocrit in Ringer solution containing (in 
mM): 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic 
acid (HEPES), 5 glucose, 1 CaCl2; pH 7.4. For Ca
2+-free Ringer solution, CaCl2 was 
replaced with 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
(EGTA) (Chem-Impex Intl., Wood Dale, IL, USA). 
Preceded DEET treatment by 30 min was the use of 50 µM BAPTA-AM (cell- 
permeable Ca2+ chelator), 2 µM of PKC inhibitor, Staurosporin (StSp) (Cayman Chemical 
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Company, Ann Arbor, MI, USA), 100 µM of CK1α inhibitor, D4476 (Cayman), 50 µM of 
p38 MAPK inhibitor, SB203580 (Selleckchem, Houston, TX, USA), 100 µM of pan- 
caspase inhibitor, Z-VAD(OMe)-FMK (Cayman), 100 µM RIP1 inhibitor, necrostatin-1 
(Nec-1), or 1 µM of mixed lineage kinase domain-like pseudokinase (MLKL) inhibitor, 
necrosulfonamide (NSA). All inhibitors were dissolved in dimethyl sulfoxide (DMSO). 
Where indicated, cells were co-treated with DEET and 1 mM of N-acetylcysteine (NAC). 
All chemicals were of analytical grade and were purchased from Sigma (St. Louis, 
MO, USA) unless otherwise noted. An ethanolic stock solution of DEET was prepared at 
1 M (20% DEET) and diluted to desired concentrations (1-5 mM; 0.02-0.1%) in Ringer 
solution. This concentration range reflects DEET blood levels encountered in cases of 
accidental and intentional intoxication in humans (Tenenbein, 1987; Wiles et al., 2014); 
Handbook of Pesticide Toxicology; https://toxnet.nlm.nih.gov/cgi- 
bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+1582). Moreover, DEET at this range has 




RBCs (5% hematocrit) were treated with 1-5 mM of DEET in Ringer solution at 37°C 
for 6 h, and the degree of hemoglobin leakage was determined spectrophotometrically 
using VersaMax™ ELISA microplate reader (Molecular Devices, San Jose, CA, USA). 
Following DEET treatment, cells were pelleted by centrifugation at 13,300 × g for 1 min. 
The resulting supernatant was assayed for hemoglobin content by measuring light 
absorbance at 405 nm. Results are presented as percent hemolysis compared to cells 
suspended in distilled water (100% hemolysis). 
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PS externalization and forward scatter (FSC) 
 
Annexin-V-FITC binding was utilized as a measure of exposed PS. Briefly, following 
DEET treatment, the cells were washed in 5 mM CaCl2 Ringer solution, and a 
homogeneous 50-µl cell suspension was stained with 150 µl of 1% solution of Annexin-V- 
FITC (Thermo Fisher Scientific, Waltham, MA, USA) for 10 min away from light. FITC 
fluorescence and FSC were subsequently obtained on a FACScan (Betcon Dickinson, 
Franklin Lakes, NJ, USA) at excitation/emission wavelengths of 488/530. 
Determination of intracellular calcium 
 
Calcium was determined by Fluo3/AM cleavage (Biotium, Fremont, CA, USA). Upon 
intracellular hydrolysis of Fluo3/AM by esterases, Fluo3 fluoresces relative to Ca2+ 
binding. To determine cytosolic Ca2+ content, 50 µl of control and DEET-treated cells were 
washed and resuspended in 5 mM CaCl2 Ringer buffer, and then incubated in total darkness 
with 5 µM Fluo3/AM at 37°C for 30 min in a final volume of 200 µl. Fluorescence was 
then determined on a FACScan at excitation and emission wavelengths of 488 and 530 nm, 
respectively. 
Measurement of ROS generation 
 
ROS accumulation was measured by staining the cells with 2-,7- 
dichlorodihydrofluorescin diacetate (DCFH2-DA) (Thermo Fisher Scientific, Waltham, 
MA, USA). DCFH2-DA is non-fluorescent until cleaved by esterases and subsequently 
oxidized by ROS. A 50-µl homogeneous cell suspension was washed in Ringer buffer, 
loaded with 10 µM DCFH2-DA in a final volume of 200 µl, and incubated for 30 min at 
37°C in the dark. DCF fluorescence was then quantified by FACScan as a measure of ROS 






Data are represented as arithmetic means ± S.E.M. of triplicate measurements of three 
independent experiments conducted on RBC samples from different donors. Prism 5 
GraphPad was used for statistical analysis using Student’s t-test to compare two groups, 
and one-way ANOVA followed by Dunnett’s post-hoc test to compare treatment groups 
with the vehicle control. To account for individual variation, comparisons between 





DEET induces weak hemolysis in human RBCs 
 
Cell-free hemoglobin is a marker of hemolysis. To determine the hemolytic potential 
of DEET, RBCs were treated with 1-5 mM of DEET for 6 h at 37°C, and hemoglobin 
leakage into the medium was subsequently assayed. Fig. 1B shows that DEET causes a 
modest, yet statistically significant increase in hemolysis at both 4 and 5 mM. This 
indicates that the cell membrane could be a major action site targeted by the repellent. 
DEET causes PS externalization 
 
Membrane phospholipid scrambling, the principal feature of eryptotic cells, was 
identified by binding of externalized phosphatidylserine to Annexin-V. To identify PS- 
exposing cells, RBCs were incubated in presence and absence of 1-5 mM DEET for 6 h at 
37°C, and the percentage of Annexin-V-binding cells was determined by flow cytometry. 
As shown in Fig. 2, DEET causes a statistically significant increase in Annexin binding, 
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reflective of PS exposure. Thus, DEET stimulated eryptotic transformation of RBCs. 
 
DEET reduces erythrocyte cell volume 
 
Cell size was determined by FSC. Fig. 3 shows light scatter properties of vehicle-only 
and DEET-treated cells. A significant reduction in FSC was observed in cells exposed to 5 
mM DEET compared to the vehicle control (Fig. 3A,B). DEET also caused an increasing 
trend in the percentage of cells with reduced FSC (Fig. 3C), and a significant decrease in 
the percentage of cells with an enlarged volume (Fig. 3D). Taken together, our data show 
that DEET-induced PS exposure is accompanied by cell shrinkage – a prominent feature of 
eryptotic RBCs. 
DEET leads to elevations in intracellular Ca2+ 
 
Dysregulated Ca2+ homeostasis is a key event during eryptosis. To investigate 
perturbations in Ca2+ homeostasis caused by DEET, erythrocytes were incubated with or 
without 1-5 mM DEET for 6 h at 37°C, and mean Fluo3 fluorescence intensity was 
measured as an indicator of intracellular Ca2+. Fig. 4 reveals that a statistically significant 
elevation in intracellular Ca2+ was only observed at 5 mM DEET. This is consistent with 
the PS-exposing (Fig. 2B,C) and volume-reducing (Fig. 3A,B) effects observed at the same 
concentration. Hence, DEET induces PS externalization with accompanying cell shrinkage 
and intracellular Ca2+ accumulation. 
Next, to probe whether the observed increase in Ca2+ is secondary to extracellular Ca2+ 
influx, cells were incubated for 6 h with either the vehicle or 5 mM DEET in presence or 
nominal absence of Ca2+, and Fluo3 fluorescence was then measured. While DEET 
increased Ca2+ levels when extracellular Ca2+ was available (Fig. 5A), the increase was 
completely abolished when Ca2+ was removed from the medium (Fig. 5B). This suggests 
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that Ca2+ influx accounted for DEET-induced cytosolic Ca2+ accumulation. 
 
Finally, to determine the importance of Ca2+ availability for the PS-exposing effect of 
DEET, cells were incubated for 6 h with the vehicle or 5 mM DEET in presence and 
absence of extracellular Ca2+, or were pretreated for 30 min with 50 µM of intracellular 
Ca2+ chelator BAPTA-AM before DEET exposure. The results shown in Fig. 6 indicate 
that DEET-induced PS exposure is not significantly rescinded neither by removal of 
extracellular Ca2+ (Fig. 6A-C) nor by chelation of cytosolic Ca2+ (Fig. 6D-F). Therefore, 
PS exposure by DEET apparently does not require Ca2+, an observation possibly pointing 
at other additional mechanisms. 
DEET does not increase ROS generation 
 
The buildup of ROS aggravates eryptosis. As a measure of ROS levels, DCF 
fluorescence was determined after 6 h treatment of RBCs to 1-5 mM DEET. Fig. 7A,B 
shows that no significant increase in DCF fluorescence was observed between vehicle and 
5 mM-treated cells. As supportive evidence, the eryptotic activity of DEET was also 
examined in presence and absence of 1 mM of free radical scavenger NAC. As can be seen 
in Fig. 7C-E, DEET-induced PS exposure was not reversed by cotreatment with NAC. 
These findings suggest that DEET-induced eryptosis is not mediated through oxidative 
stress. 
DEET-induced  eryptosis  is  not  dependent  on   a   specific   signaling   pathway 
The role of signaling mediators is fundamental to various cellular functions and 
responses, most importantly cell survival. To dissect the involvement of signaling enzymes 
in DEET-induced PS exposure, cells were pretreated for 30 min with specific inhibitors 
and then exposed to 5 mM DEET for 6 h at 37°C. As seen in Fig. 8, DEET-induced PS 
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externalization is not significantly reduced in presence of respective inhibitors of caspases 
(100 µM Z-VAD(OMe)-FMK), p38 MAPK (50 µM SB203580), PKC (2 µM StSp), or 
CK1 (100 µM D4476). Furthermore, blockade of necroptosis mediators, RIP1 (100 µM 
Nec-1) and MLKL (1 µM NSA), have similarly failed to protect RBCs from DEET-induced 
cell death (Fig. 9). Collectively, our data indicate that DEET-induced suicidal RBC death 





DEET is considered the gold standard of insect repellents, and formulations containing 
DEET are more effective than those without it (Tintinalli and Stapczynski, 2011). 
Environmental and public health agencies encourage DEET use, and more consumption is 
indeed on the horizon (Chen-Hussey et al., 2014). Although no adverse effects on RBCs 
following DEET exposure have been observed in humans, reduced hemoglobin and 
hematocrit found in small-scale animal studies were either unreliable or not associated with 
DEET treatment (https://www.atsdr.cdc.gov/toxprofiles/tp185.pdf; 
https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+1582). In 
particular, DEET exposure was reported to increase RBC count in Cyprinus carpio fish 
(Slaninova et al., 2014). Nevertheless, our data show that DEET reduces human RBC 
lifespan by stimulating premature eryptosis, characterized by PS externalization, Ca2+ 
influx, and cell shrinkage. It must be stressed, however, that these observations were only 
evident at DEET concentrations that parallel those detected in the blood of individuals 
following accidental and suicidal exposure. Use of DEET at the recommended doses is, 
therefore, unlikely to be detrimental to erythrocyte health. 
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Although minimal, the statistically significant increase in hemolysis brought about by 
DEET suggests that the repellent is capable of inflicting direct membrane damage and 
eventual cell destruction. This hemolytic effect could be augmented in cases of enhanced 
RBC vulnerability such as diabetes, cancer, and hemoglobinopathies (Rytting et al., 1996; 
James and Meyers, 1998; Kato et al., 2017). Hemolysis leads to a spill out of cellular 
contents, most notably hemoglobin, which participates in both acute and chronic injuries 
to vital organs. Nitric oxide depletion and oxidative damage, hypertension, and vascular 
occlusion are consequences of circulating hemoglobin (Doherty et al., 1998). Prolonged 
presence of hemoglobin in the circulation eventually leads to endothelial dysfunction and 
atherosclerosis (Minneci et al., 2005; Nagy et al., 2010). When hemoglobin escapes the 
circulation, impaired hepatic iron metabolism, tubular injury and renal failure, and immune 
dysfunction may follow (Schaer et al., 2013). 
The central finding in this report is the ability of DEET to cause loss of the RBC 
membrane asymmetry culminating in PS externalization. The presence of PS on the outer 
membrane leaflet represents a binding site for receptors on phagocytes for elimination of 
defective RBCs (Niemoeller et al., 2006). Therefore, physiologic eryptosis may be 
perceived as an insurance policy safeguarding against hemolysis. However, excessive and 
premature RBC death, as observed in the case of DEET, may outweigh their rate of 
clearance, thereby leading to hemolysis and compromised tissue oxygenation. Similarly, 
inordinate RBC death may outpace erythropoiesis in the bone marrow eventually causing 
anemia (Lang et al., 2008). 
Recent efforts also recognize the effects of eryptosis on hemorheology. For RBCs to 
efficiently carry out oxygen transport, they must withstand mechanical forces in the 
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circulation, which requires extreme structural flexibility. This is mediated by remarkable 
deformability and aggregability of healthy erythrocytes which is significantly 
compromised in eryptotic corpses (Pretorius, 2018). The alterations associated with 
eryptosis limit the capacity of the RBC membrane to deform, leading to increased blood 
flow resistance, hemodynamic stasis, and ultimately reduced tissue perfusion (du Plooy et 
al., 2018; Pretorius, 2018). Moreover, eryptotic RBCs adhere to transmembrane CXC 
chemokine ligand 16 (CXCL16) present on vascular endothelial cells (Borst et al., 2012), 
which have been shown to be susceptible to the proangiogenic activity of DEET (Legeay 
et al., 2016). Thus, eryptosis may have ramifications beyond the development of anemia, 
which include vaso-occlusive thromboembolic lesions and ischemic injury. At the 
molecular level, DEET has been found to cause DNA damage in primary human nasal 
mucosal cells (Tisch et al., 2002), and to modulate transcriptional activities of metabolic, 
oxidoreductive, and signal transduction genes in primary human hepatocytes (Das et al., 
2008; Mitchell et al., 2016). 
Parallel to PS exposure, we have also detected significant cell shrinkage – a distinctive 
feature of eryptotic cells. Diminished cell size is thought to be a consequence of Ca2+ 
channel opening and the ion’s intracellular accumulation, an event also detected in our 
study (Fig. 4 & 5). The buildup of Ca2+ leads to opening of Ca2+-sensitive K+ channels, 
membrane hyperpolarization due to KCl efflux, water loss by osmotic forces, and cell 
shrinkage (Lang and Lang, 2015a). Presumably, smaller, eryptotic cells may facilitate 
engulfment and degradation by larger phagocytes thus expediting their clearance from the 
circulation. 
Calcium signaling is a major orchestrator of programmed cell death. Scramblases are 
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Ca2+-sensitive enzymes responsible for the bidirectional movement of phospholipids 
within the lipid bilayer. Accumulation of Ca2+ therefore impinges on scramblase regulation 
and leads to loss of membrane asymmetry (Weiss et al., 2012). Our experiments revealed 
an increase in Ca2+ as part of DEET-mediated eryptosis (Fig. 4), that was chiefly through 
influx from the medium (Fig. 5). Based on the dispensability of the ion to DEET-induced 
PS externalization (Fig. 6), other possible mechanisms leading up to membrane scrambling 
cannot be excluded. In this regard, DEET resembles the eryptotic behavior of caspofungin 
(Peter et al., 2016a), micafungin (Peter et al., 2016c), and exemestane (Al Mamun Bhuyan 
et al., 2017a). 
Oxidative stress is among the major manifestations of eryptotic cells, and a number of 
life-threatening conditions lie at the intersection of oxidative stress and enhanced eryptosis, 
most notably diabetes, hepatic failure, and malignancy (Bissinger et al., 2018). It has 
previously been demonstrated that ROS accumulation stimulates the activity of Ca2+- 
permeable cation channels and thus promotes intracellular Ca2+ overload with subsequent 
PS externalization (Lang et al., 2012). Also secondary to oxidative stress is caspase 
activation (Pretorius et al., 2016). Our data in Fig. 7 indicate that DEET-induced PS 
exposure occurs independently of oxidative stress as was observed for caspofungin (Peter 
et al., 2016a), micafungin (Peter et al., 2016c), anidulafungin (Peter et al., 2016b), and 
sclareol (Signoretto et al., 2016). It is worth mentioning that various endo- and xenobiotics 
have been shown to possess a protective role against eryptosis in part by counteracting 
oxidative stress (Lang and Lang, 2015b). 
In order to identify the molecular pathways through which DEET reduces the RBC 
lifespan, we have employed a series of small-molecule inhibitors to scan for signaling 
202  
mediators involved in two cell death pathways; eryptosis and necroptosis. Our attempts in 
this regard were not fruitful as DEET still exposed PS under inhibition of all major cell 
death pathways (Fig. 8 & 9). It may be, however, that DEET does not require the specific 
action of a signaling mediator, or that a prominent role of such a player only becomes 
apparent at a later point during cell death. Another possibility is that DEET may activate 
multiple pathways such that inhibition of one is still outweighed by others. 
In conclusion, this investigation identified DEET as a stimulator of erythrocyte 
membrane scrambling with concurrent cell shrinkage and elevated intracellular Ca2+ 
mainly through Ca2+ entry from the extracellular space. Recent analysis concludes that 
DEET is both more toxic and less efficacious compared to other repellents including IR 
3535, Picaridin, and oil of lemon eucalyptus (p-menthane-3, 8-diol; PMD) (Diaz, 2016; 
Tavares et al., 2018). In fact, the existence of a DEET-sensitive receptor makes it possible 
to devise potentially safer alternatives (Leal, 2014). Thus, combined with entomological 
and epidemiological studies, examination of the biochemical and molecular interactions of 
current DEET competitors, Picaridin, IR 3535, and essential oils, and new repellents (e.g., 
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Figure 1. DEET induces minor hemolysis. (A) Molecular structure of DEET. (B) RBCs 
were exposed to 1-5 mM DEET for 6 h at 37°C after which the supernatant was 
spectrophotometrically tested for hemoglobin content at a wavelength of 405 nm. Data are 
means + S.E.M. (n = 9). *(P < 0.05) indicates significant difference from vehicle-treated 
cells (ANOVA). 
 
Figure 2. DEET stimulates PS exposure. (A) Representative histograms showing 
Annexin-V-FITC fluorescence of RBCs treated with either the vehicle or 1-5 mM DEET 
for 6 h at 37°C. (B) Overlay histogram showing Annexin-V-FITC fluorescence by vehicle 
and 5 mM DEET-treated RBCs. (C) Arithmetic means + S.E.M. (n = 9) of the percentage 
of cells bound to Annexin-V following exposure either to the vehicle or to 1-5 mM DEET 
for 6 h at 37°C. ***(P<0.001) indicates significant difference from the absence of DEET 
(ANOVA). 
 
Figure 3. DEET reduces forward scatter. (A) Overlay histogram showing FSC of RBCs 
treated with the vehicle (grey peak) and those with 5 mM DEET (orange peak) for 6 h at 
37°C. (B) Arithmetic means + S.E.M. (n = 9) of mean FSC values for cells exposed to the 
vehicle or to 1-5 mM DEET for 6 h at 37°C. *(P < 0.05) indicates significant difference 
from vehicle-treated cells (ANOVA). (C) Arithmetic means + S.E.M. (n = 9) of the 
percentage of cells, exposed to the vehicle or to 1-5 mM DEET for 6 h at 37°C, with mean 
FSC of <200. (D) Arithmetic means + S.E.M. (n = 9) of the percentage of cells, exposed 
to the vehicle or to 1-5 mM DEET for 6 h at 37°C, with mean FSC of >400. *(P < 0.05) 
indicates significant difference from vehicle-treated cells (ANOVA). 
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Figure 4. DEET increases intracellular Ca2+ levels. (A) Representative histograms 
showing Fluo3 fluorescence of RBCs treated with either the vehicle or 1-5 mM DEET for 
6 h at 37°C. (B) Overlay histogram showing Flou3 fluorescence by vehicle and 5 mM 
DEET-treated RBCs. (C) Arithmetic means + S.E.M. (n = 9) of mean Fluo3 fluorescence 
by RBCs exposed to the vehicle or to 1-5 mM DEET for 6 h at 37°C. ***(P<0.001) 
indicates significant difference from the absence of DEET (ANOVA). 
Figure 5. Effect of extracellular Ca2+ removal on cytosolic Ca2+ levels. (A) Overlay 
histogram showing Fluo3 fluorescence of RBCs exposed to the vehicle only (black line) or 
to 5 mM DEET (turquoise line) in Ringer solution for 6 h at 37°C. (B) Overlay histogram 
showing Fluo3 fluorescence of RBCs exposed to the vehicle only (black line) or to 5 mM 
DEET (green line) in Ca2+-free Ringer solution for 6 h at 37°C. (C) Arithmetic means + 
S.E.M. (n = 9) of mean Fluo3 fluorescence by RBCs exposed to the vehicle or to 1-5 mM 
DEET for 6 h at 37°C in presence and absence of extracellular Ca2+. ***(P <0.001) 
indicates significant difference from the absence of DEET. ##(P <0.01) indicates 
significant difference from the corresponding treatment condition in presence of Ca2+ 
(ANOVA). 
Figure 6. Effect of Ca2+ removal on PS externalization. (A) Overlay histogram showing 
Annexin-V-FITC fluorescence of RBCs exposed to the vehicle (black line) only or to 5 
mM DEET (purple line) in Ringer solution for 6 h at 37°C. (B) Overlay histogram showing 
Annexin-V-FITC fluorescence of RBCs exposed to the vehicle only (black line) or to 5 
mM DEET (pink line) in Ca2+-free Ringer solution for 6 h at 37°C. (C) Arithmetic means 
+ S.E.M. (n = 9) of the percentage of cells bound to Annexin-V following treatment with 
 
the vehicle or with 1-5 mM DEET for 6 h at 37°C in presence and absence of extracellular 
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Ca2+. ***(P <0.001) indicates significant difference from the absence of DEET (ANOVA). 
 
(D) Overlay histogram showing Annexin-V-FITC fluorescence of RBCs exposed to the 
vehicle only (black line) or to 5 mM DEET (blue line) for 6 h at 37°C. (E) Overlay 
histogram showing Annexin-V-FITC fluorescence of RBCs pretreated with 50 µM 
BAPTA-AM for 30 min at 370C and then exposed to the vehicle only (black line) or to 5 
mM DEET (rose line) for 6 h at 37°C. (F) Arithmetic means + S.E.M. (n = 9) of the 
percentage of cells bound to Annexin-V following treatment with the vehicle or with 1-5 
mM DEET for 6 h at 37°C without and with BAPTA-AM pretreatment. ***(P <0.001) 
indicates significant difference from the absence of DEET (ANOVA). 
Figure 7. Lack of oxidative stress in DEET-induced PS externalization. (A) Overlay 
histogram showing DCF fluorescence of RBCs exposed to the vehicle only (black line) or 
to 5 mM DEET (green line) in Ringer solution for 6 h at 37°C. (B) Arithmetic means + 
S.E.M. (n = 9) of DCF fluorescence following treatment with the vehicle or with 5 mM 
DEET for 6 h at 37°C. ns (P >0.05) indicates insignificant difference from the absence of 
DEET (t-test). (C) Overlay histogram showing Annexin-V-FITC fluorescence of RBCs 
exposed to the vehicle only (black line) or to 5 mM DEET (red line) for 6 h at 37°C. (D) 
Overlay histogram showing Annexin-V-FITC fluorescence of RBCs exposed to the vehicle 
only (black line) or to a combination of 1 mM NAC and 5 mM DEET (turquoise line) for 
6 h at 37°C. (E) Arithmetic means + S.E.M. (n = 9) of the percentage of cells bound to 
Annexin-V following treatment with the vehicle, NAC, 5 mM DEET, or following 
cotreatment with NAC and 5 mM DEET for 6 h at 37°C. ***(P <0.001) indicates 
significant difference from the absence of DEET (ANOVA). 
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Figure 8. Effect of eryptosis inhibitors on DEET-induced PS exposure. (A-E) Overlay 
histograms showing Annexin-V fluorescence of RBCs exposed for 6 h at 37°C to the 
vehicle only (black line) or to 5 mM DEET without (red line, A) or with pretreatment for 
30 min with 100 µM Z-VAD(OMe)-FMK (purple line, B), 2 µM StSp (orange line, C), 100 
µM D4476 (blue line, D), or 50 µM SB (green line, E). (F) Arithmetic means + S.E.M. (n 
= 9) of the percentage of cells bound to Annexin-V following treatment for 6 h at 37°C 
with the vehicle or 5 mM DEET with and without pretreatment with Z-VAD(OMe)-FMK, 
StSp, D4476, or SB. ***(P <0.001) indicates significant difference from the absence of 
DEET (ANOVA). 
Figure 9. Effect of necroptosis inhibitors on DEET-induced PS exposure. (A-C) 
Overlay histograms showing Annexin-V fluorescence of RBCs exposed for 6 h at 37°C to 
the vehicle only (black line) or to 5 mM DEET without (blue line, A) or with pretreatment 
for 30 min with 100 µM Nec-1 (rose line, B) or 1 µM NSA (pink line, C). (D) Arithmetic 
means + S.E.M. (n = 9) of the percentage of cells bound to Annexin-V following treatment 
for 6 h at 37°C with the vehicle or 5 mM DEET with and without pretreatment with either 
Nec-1 or NSA. ns (P >0.05) indicates insignificant difference. ***(P <0.001) indicates 












































































CHAPTER VI: SUMMARY 
 
 
The studies presented herein collectively support the following conclusions: (1) 
TCS is an effective antileukemic agent, evident by its pro-apoptotic properties 
demonstrated against BL cells in vitro; (2) TCS has a potent hemolytic and eryptotic 
potential against human RBCs; and (3) TCS is susceptible to inactivation by noncharged 
detergents often present in drug formulae as excipients. 
In chapter II, TCS was demonstrated to induce apoptosis in blood cancer cells, 
which is a very common action mechanism of chemotherapeutic drugs. At the molecular 
level, TCS disrupts the cell membrane permeability, leads to cytosolic Ca2+ overload, 
which in turn causes loss of membrane asymmetry, activates caspase, and induces 
systematic DNA fragmentation. In parallel, TCS interferes with antioxidant enzyme 
expression leading to excessive ROS accumulation and oxidative stress. This redox 
imbalance similarly stimulates caspase activity and JNK signaling; two pathways that were 
shown to be essential for TCS-induced apoptosis in Burkitt lymphoma cells. Of particular 
interest is the ability of TCS to favorably modulate the transcriptional regulation of survival 
genes (e.g., BCL2) that are common pharmaceutical targets in existing chemotherapies. 
Our study on TCS influence on RBC survival identified the antimicrobial as both 
pro-hemolytic and pro-eryptotic. Mechanistically, TCS was found to inflict direct 
membrane damage resulting in profound hemolysis, and cause a breakdown of membrane 
asymmetry culminating in phosphatidylserine externalization. As is the case with 
lymphoma cells, TCS increased cytoplasmic Ca2+ levels, but, conversely, was not pro- 
oxidative in erythrocytes. Employing a small-molecule inhibitor screening approach, we 
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were able to discern the indispensable roles of p38 MAPK and RIP1 as essential 
requirements for TCS-induced eryptosis. These findings suggest that caution with TCS use 
must be exercised given its potential contribution to the development of chemotherapy- 
induced anemia in cancer patients. Chapter IV unequivocally showed that nonionic 
detergents act as antagonists of TCS in vivo most likely through micellar solubilization. 
This is significant as noncharged detergents are incorporated as excipients in drug 
formulations which must be taken into consideration for drug development. 
Building on present observations, future efforts must be directed toward identifying 
whether or not TCS effects described herein and elsewhere are reciprocated in highly 
relevant animal models. Equally important is the identification of molecular and cellular 
mechanisms modulated by TCS in human-based systems (reviewed in chapter I). The 
advent of nanotechnology and monoclonal antibody-based therapies, along with the 
discovery of miRNA regulators similarly paves the way to numerous opportunities to 
further exploit TCS for therapeutic or prophylactic purposes. 
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